2024/08/19 更新
新型コロナウイルス感染症（COVID-19）についてNCGMが発表した学術論文
NCGMはCOVID-19対応にあたるほか、学術論文を発表することによって、COVID-19対応を通じて得た経験や研究成果を、人類共有の財産として蓄積・継承してまいります。
このページでは、NCGM職員が携わったCOVID-19関連論文（512報）をリスト形式で紹介しています。
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.5582/bst.2020.01056

なし

https://doi.org/10.5582/bst.2020.01482

あり

https://doi.org/10.35772/ghm.2020.01019

なし

https://doi.org/10.1001/jama.2020.6173

なし

https://doi.org/10.1056/NEJMoa2007016

なし

https://doi.org/10.1016/j.onehlt.2020.100131

なし

https://doi.org/10.35772/ghm.2020.01018

あり

https://doi.org/10.35772/ghm.2020.01028

あり

https://doi.org/10.35772/ghm.2020.01029

あり

https://doi.org/10.35772/ghm.2020.01023

あり

https://doi.org/10.35772/ghm.2020.01026

なし

https://doi.org/10.35772/ghm.2020.01030

あり

https://doi.org/10.35772/ghm.2020.01031

あり

https://doi.org/10.35772/ghm.2020.01034

あり

https://doi.org/10.35772/ghm.2020.01037

あり

https://doi.org/10.35772/ghm.2020.01040

なし

https://doi.org/10.35772/ghm.2020.01041

あり

https://doi.org/10.35772/ghm.2020.01036

あり

https://doi.org/10.35772/ghm.2020.01038

なし

https://doi.org/10.35772/ghm.2020.01035

あり

https://doi.org/10.35772/ghm.2020.01043

あり

https://doi.org/10.1016/j.ijid.2020.04.068

あり

https://doi.org/10.1016/j.psychres.2020.113040

あり

Song P, Karako T.
1

2020/2/25

COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern.
Biosci Trends. 2020;14(1):1‐2.
Karako K, Song P, Chen Y, Tang W.

2

2020/3/19

Analysis of COVID-19 infection spread in Japan based on stochastic transition model.
Biosci Trends. 2020;14(2):134-138.
Norihiro Kokudo, Haruhito Sugiyama.

3

2020/4/10

Call for international cooperation and collaboration to effectively tackle the COVID-19 pandemic.
Global Health & Medicine. 2020; 2(2):60-62.
Sakamoto H, Ishikane M, Ueda P.

4

2020/4/10

Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan.
JAMA. 2020;323(19):1969‐1971.
Grein J, Ohmagari N, Shin D, et al.

6

2020/4/10

Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N Engl J Med. 2020;382(24):2327-2336.
Picot S, Marty A, Bienvenu AL, et al.

5

2020/4/4

Coalition: Advocacy for prospective clinical trials to test the post-exposure potential of hydroxychloroquine against COVID19.
One Health. 2020;9:100131.
Umeda A, Sugiki Y.

7

2020/4/16

Nursing care for patients with COVID-19 on extracorporeal membrane oxygenation (ECMO) support.
Global Health & Medicine.2020;2(2):127-130.
Nagai M, Oikawa M, Tamura T, Egami Y, Fujita N.

8

2020/4/19

Can we apply lessons learned from Ebola experience in West Africa for COVID-19 in lower income countries?
Global Health & Medicine. 2020;2(2):140-141.
Obara H, Noda S, Fujita N, Miyoshi C, Akashi H.

92020/4/21

Sustainable implementation of international health cooperation projects while Japanese technical experts cannot go to
low- and middle-income countries because of the COVID-19 pandemic travel restrictions.
Global Health & Medicine. 2020;2(2):148-150.
Nozaki I, Miyano S.

10

2020/4/21

The necessity of continuous international cooperation for establishing the coronavirus disease 2019 diagnostic capacity
despite the challenges of fighting the outbreak in home countries.
Global Health & Medicine. 2020;2(2):145-147.
Peipei Song, Takashi Karako.

11

2020/4/22

Scientific solidarity in the face of the COVID-19 pandemic: researchers, publishers, and medical associations.
Global Health & Medicine. 2020; 2(2):56-59.
Iwamoto A, Tung R, Ota T, Hosokawa S, Matsui M.

12

2020/4/23

Challenges to neonatal care in Cambodia amid the COVID-19 pandemic.
Global Health & Medicine. 2020;2(2):142-144.
Kutsuna S.

13

2020/4/26

Coronavirus disease 2019 (COVID-19): research progress and clinical practice.
Global Health & Medicine. 2020;2(2):78-88.
Ito K, Ohmagari N, Mikami A, Sugiura W.

14

2020/4/29

Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan.
Global Health & Medicine. 2020;2(2):96-101.
Tsuboi M, Hachiya M, Noda S, Iso H, Umeda T.

17

2020/4/29

Epidemiology and quarantine measures during COVID-19 outbreak on the cruise ship Diamond Princess docked at
Yokohama, Japan in2020: a descriptive analysis.
Global Health & Medicine. 2020;2(2):102-106.
Hiroaki Mitsuya, Norihiro Kokudo.

20

2020/4/30

Sustaining containment of COVID-19: global sharing for pandemic response.
Global Health & Medicine. 2020; 2(2):53-55.
Kuwahara K, Hori A, Ohmagari N, Mizoue T.

18

2020/4/29

Early cases of COVID-19 in Tokyo and occupational health.
Global Health & Medicine. 2020;2(2):118-122.
Hayakawa K, Kutsuna S, Kawamata T, Sugiki Y, Nonaka C, Tanaka K, Shoji M, Nagai M, Tezuka S, Shinya K, Saito H,
Harada T, Moriya N, Tsuboi M, Norizuki M, Sugiura Y, Osanai Y, Sugiyama M, Okuhama A, Kanda K,Wakimoto Y , Ujiie M,
Morioka S, Yamamoto K, Kinoshita N, Ishikane M, Saito S, Moriyama Y, Ota M, Nakamura K, Nakamoto T, Ide S, Nomoto H,
Akiyama Y, Suzuki T, Miyazato Y, Gu Y, Matsunaga N, Tsuzuki S, Fujitomo Y, Kusama Y, Shichino H, Kaneshige M,

16

2020/4/29

Yamanaka J, Saito M, Hojo M, Hashimoto M, Izumi S, Takasaki J, Suzuki M, Sakamoto K, Hiroi Y, Emoto S, Tokuhara M,
Kobayashi T, Tomiyama K, Nakamura F, Ohmagari N, Sugiyama H.
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for
Global Health and Medicine.
Global Health & Medicine. 2020;2(2):107-111.
Hanako Jimi, Gaku Hashimoto.

19

2020/4/29

Challenges of COVID-19 outbreak on the cruise ship Diamond Princess docked at Yokohama, Japan: a real-world story.
Global Health & Medicine. 2020; 2(2):63-65.
Yano H.

15

2020/4/24

The National Health Service (NHS) response to the COVID-19 pandemic: a colorectal surgeon’s experience in the UK.
Global Health & Medicine. 2020;2(2):138-139.
Inoue H.

21

2020/4/30

Japanese strategy to COVID-19: How does it work?
Global Health & Medicine. 2020; 2(2):131-132.
Ujiie M, Tsuzuki S, Ohmagari N.

22

2020/4/30

Effect of temperature on the infectivity of COVID-19.
Int J Infect Dis. 2020;95:301‐303.
Morioka S, Saito S, Hayakawa K, Takasaki Jin, Suzuki T, Ide S, Nakamura K, Moriyama Y, Akiyama Y, Miyazato Y, Nomoto
H, Nakamoto T, Ota M, Sakamoto K, Katsuno T, Kusaba Y, Ishikane M, Kinoshita N, Ohmagari N.

23

2020/4/29

Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory
syndrome coronavirus-2 isolated in a tertiary care hospital.
Psychiatry Res. 2020;289:113040.

1

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/j.jiac.2020.05.002あり

https://doi.org/10.35772/ghm.2020.01044

あり

https://dx.doi.org/10.21037/atm-20-2618

あり

https://doi.org/10.5582/bst.2020.03093

なし

https://doi.org/10.7883/yoken.JJID.2020.240あり

https://doi.org/10.1056/NEJMoa2007764

なし

https://doi.org/10.1002/jmv.26102

あり

https://doi.org/10.35772/ghm.2020.01046

あり

https://doi.org/10.1016/j.ajic.2020.05.034あり

https://doi.org/10.1159/000508062

あり

https://doi.org/10.1093/ofid/ofaa243あり

https://doi.org/10.1093/jtm/taaa107あり

https://doi.org/10.1080/23744235.2020.1784999

あり

https://doi.org/10.35772/ghm.2020.01054

あり

https://doi.org/10.1016/j.gene.2020.144944

あり

https://doi.org/10.1097/CCE.0000000000000170

あり

https://doi.org/10.1016/j.infpip.2020.100079

あり

https://doi.org/10.3201/eid2611.201956

あり

https://doi.org/10.6009/jjrt.2020_JJRT_76.7.761

あり

https://doi.org/10.7883/yoken.JJID.2020.531

あり

https://doi.org/10.35772/ghm.2020.01056

あり

Suzuki T, Kutsuna S, Nakamura K, Ide S, Moriyama Y, Saito S, Morioka S, Ishikane M, Kinoshita N, Hayakawa K, Ohmagari
N.
24

2020/5/8

Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results inthe early phase of infection.
J Infect Chemother. 2020;26(8):851-853.
Sato R, Ishikane M, Kinoshita N, Suzuki T, Nakamoto T, Hayakawa K, Bekki N, Hara H, Ohmagari N.

25

2020/5/15

A new challenge of unfractionated heparin anticoagulation treatment for moderate to severe COVID-19 in Japan.
Global Health & Medicine. 2020;2(2):190-192.
Wang H, Song P, Gu Y, Schroeder E, Jin C.

26

2020/5/13

Rapid health systems change: online medical consultations to fight COVID-19.
Ann Transl Med. 2020;8(11):726.
Wang X, Wu W, Song P, He J.

27

2020/5/9

An international comparison analysis of reserve and supply system for emergency medical supplies between China, theUnited States, Australia, and Canada.
BioScience Trends. 2020;14(4):231-240.
Ishikane M, Miyazato Y, Kustuna S, Suzuki T, Ide S, Nakamura K, Morioka S, Katano H, Suzuki T, Ohmagari N.

28

2020/5/29

A Case of COVID-19 Patient with False-negative for SARS-CoV-2 of Pharyngeal Swab, from a Chinese traveller Returningfrom Wuhan, Hubei Province, China, January 2020.
Jpn J Infect Dis. 2020;73(6):462-464.
J.H. Beigel, K.M. Tomashek, L.E. Dodd, A.K. Mehta, B.S. Zingman, A.C. Kalil,
E. Hohmann, H.Y. Chu, A. Luetkemeyer, S. Kline, D. Lopez de Castilla,
R.W. Finberg, K. Dierberg, V. Tapson, L. Hsieh, T.F. Patterson, R. Paredes,
D.A. Sweeney, W.R. Short, G. Touloumi, D.C. Lye, N. Ohmagari, M. Oh,

29

2020/5/22

G.M. Ruiz-Palacios, T. Benfield, G. Fätkenheuer, M.G. Kortepeter, R.L. Atmar,
C.B. Creech, J. Lundgren, A.G. Babiker, S. Pett, J.D. Neaton, T.H. Burgess,T. Bonnett, M. Green, M. Makowski, A. Osinusi, S. Nayak, and H.C. Lane,for the ACTT-1 Study Group Members.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
N Engl J Med. 2020;383(19):1813-1826.
Nakamoto T, Kutsuna S, Yanagawa Y, Kanda K, Okuhama A, Akiyama Y, Miyazato Y, Ide S, Nakamura K, Yamamoto K,

30

2020/6/3

Ohmagari N.
A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
J Med Virol. 2021;93(1):40-42.
Matsuda W, Okamoto T, Uemura T, Kobayashi K, Sasaki R, Kimura A.

31

2020/5/30

Corticosteroid therapy for severe COVID-19 pneumonia: optimal dose and duration of administration.
Global Health & Medicine. 2020;2(3):193-196.
Nomoto H, Ishikane M, Katagiri D, Kinoshita N, Nagashima M,Sadamasu K, Yoshimura K, Ohmagari N.

32

2020/6/2

Cautious handling of urine from moderate to severe COVID-19 patients.
Am J Infect Control. 2020;48(8):969-971.
Katagiri D, Ishikane M, Ogawa T, Kinoshita N, Katano H, Suzuki T, Fukaya T, Hinoshita F, Ohmagari N.

33

2020/6/11

Continuous Renal Replacement Therapy for a Patient with Severe COVID-19.
Blood Purif. 2021;50(1):129-131.
Kutsuna S, Suzuki T, Hayakawa K, Tsuzuki S, Asai Y, Suzuki T, Ide S, Nakamura K, Moriyama Y, Kinoshita N, Hosokawa N,
Osawa R, Yamamuro R, Akiyama Y, Miyazato Y, Nomoto H, Nakamoto T, Ota M, Saito S, Ishikane M, Morioka S, Yamamoto34

2020/6/20

K, Ujiie M, Terada M, Nakamura-Uchiyama F, Sahara T, Sano M, Imamura A, Sekiya N, Fukushima K, Kawana A, Fujikura
Y, Sano T, Suematsu R, Sakamoto N, Nagata K, Kato T, Katano H, Wakita T, Sugiyama H, Kokudo N, Ohmagari N.
SARS-CoV-2 screening test for Japanese returnees from Wuhan, China, January 2020.
Open Forum Infect Dis. 2020;7(7):ofaa243.
Ujiie M, Ohmagari N, Inoue H.

35

2020/6/27

Testing for COVID-19 at travel clinics in Japan.
J Travel Med. 2020;27(5):taaa107.
Katsuno T, Suzuki M, Ishikane M, Kinoshita N, Tsukada A, Morita C, Kusaba Y, Sakamoto K, Yamaguchi Y, Tsujimoto Y,
Hashimoto M, Terada J, Takasaki J, Izumi S, Okuhama A, Ide S, Moriyama Y, Matsuda K, Takamatsu Y, Mitsuya H, Hojo M,

36

2020/7/2

Sugiyama H.
A familial cluster of severe coronavirus disease 2019 that required intubation of all family members.
Infectious Diseases. 2020;52(10):755-758.
Nakamura K, Ide S, Saito S, Kinoshita N, Kutsuna S, Moriyama Y, Suzuki T, Ota M, Nomoto H, Mizoue T, Hojo M, Takasaki
J, Asai Y, Terada M, Akiyama Y, Miyazato Y, Nakamoto T, Wakimoto Y, Ujiie M, Yamamoto K, Ishikane M, Morioka S,

37

2020/6/27

Hayakawa K, Sugiyama H, Ohmagari N.
COVID-19 can suddenly become severe: a case series from Tokyo, Japan.
Global Health & Medicine. 2020;2(3):174-177.
Yamamoto N, Ariumi Y, Nishida N, Yamamoto R, Bauer G, Gojobori T, Shimotohno K, Mizokami M.

38

2020/7/3

SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1I/D genotype.
Gene. 2020;758:144944.
Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y, Ide S, Nakamura K, Nakamoto T, Nomoto H, Akiyama Y,
Miyazato Y, Suzuki T, Okuhama A, Kanda K, Wakimoto Y, Morioka S, Saito S, Yamamoto K, Ujiie M, Hayakawa K, Kustuna

39

2020/7/31

S, Yanagawa Y, Terada J, Takasaki J, Izumi S, Hojo M, Hinoshita F, Sugiyama M, Noiri E, Mizokami M, Ohmagari N,
Sugiyama H.
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers.
Crit Care Explor. 2020;2(8):e0170.
Morioka S, Nakamura K, Iida S, Kutsuna S, Kinoshita N, Suzuki T, Suzuki T, Yamamoto K, Hayakawa K, Saito S, Ohmagari

40

2020/7/30

N.
Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A casestudy.
Okuhama A, Ishikane M, Katagiri D, Kanda K, Nakamoto T, Kinoshita N, Nunose N, Fukaya T, Kondo I, Katano H, Suzuki T,

41

2020/7/30

Ohmagari N, Hinoshita F.
Detection of SARS-CoV-2 in hemodialysis effluent of patient with COVID-19 pneumonia, Japan.
Emerg Infect Dis. 2020;26(11):2758-2761.
齋藤 郁里, 堀川 大輔, 竹内 智弥, 水沼 文孝, 山田 唯, 弘中 さつき, 梶原 宏則, 堀田 昌利, 松永 太, 南本 亮吾.

43

2020/7/20

COVID-19 既感染者の PET/CT 検査を実施して.
日本放射線技術学会雑誌, 76 巻 (2020) 7 号:761-767.
Yamamoto K, Saito S, Hayakawa K, Hashimoto M, Takasaki J, Ohmagari N.

42

2020/8/3

When should clinicians repeat SARS-CoV-2 RT-PCR?: Repeat PCR testing targeting patients with pulmonary CT findings
suggestive of COVID-19.
Jpn J Infect Dis. 2021;74(2):161-165.
Minamimoto R, Hotta M, Ishikane M, Inagaki T.

44

2020/7/20

FDG-PET/CT images of COVID-19: a comprehensive review.
Global Health & Medicine.2020;2(4):221-226.

2

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1093/infdis/jiaa437

なし

https://doi.org/10.1007/s11604-020-01026-z

あり

Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K, Suzuki M, Gu Y, Sakaguchi M, Tajima T,
Takaya S, Ohmagari N, Takeda M, Matsuyama S, Shirato K, Nao N, Hasegawa H, Kageyama T, Takayama I, Saito S, Wada
45

2020/7/21

K, Fujita R, Saito H, Okinaka K, Griffith M, Elizabeth Parry A, Barnetson B, Leonard J, Wakita T.
Environmental sampling for severe acute respiratory syndrome coronavirus 2 during COVID-19 outbreak in the Diamond
Princess cruise ship.
J Infect Dis. 2020;222(7):1098-1102.
Machitori A, Noguchi T, Kawata Y, Horioka N, Nishie A, Kakihara D, Ishigami K, Aoki S, Imai Y.

46

2020/8/7

Computed tomography surveillance helps tracking COVID-19 outbreak.
Jpn J Radiol. 2020;38(12):1169-1176.
Oda R, Inagaki T, Ishikane M, Hotta M, Shimomura A, Sato M, Nakamoto T, Akiyama Y, Yamamoto K, Minamimoto R,

47

2020/8/11

Kaneko H, Ohmagari N.

http://dx.doi.org/10.1136/annrheumdis-2020-

Case of adult large vessel vasculitis after SARSCoV-2 infection.

218440あり

Ann Rheum Dis. 2020.
Hattori S-i, Higshi-Kuwata N, Raghavaiah J, Das D, Bulut H, Davis D, Takamatsu Y, Matsuda K, Takamune N, Kishimoto N,
48

2020/8/20

Okamura T, Misumi S, Yarchoan R, Maeda K, Ghosh A, Mitsuya H.
GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.

https://doi.org/10.1128/mBio.01833-20

あり

mBio. 2020;11:e01833-20.
Kusaba Y, Izumi S , Takasaki J, Suzuki M, Katagiri D, Katsuno T, Matsumoto S, Sakamoto K, Hashimoto M, Ohmagari N,
Katano H, Suzuki T, Hojo M, Sugiyama H.
49

2020/8/29

Successful Recovery from COVID-19-associated Acute Respiratory Failure with Polymyxin B-immobilized Fiber Columndirect Hemoperfusion.

https://doi.org/10.2169/internalmedicine.541320

あり

Internal Medicine. 2020;59(19):2405-2408.
Uemura T, Matsuda W, Ogawa T.
50

2020/8/13

Concerns About the Timing and Settings of Initiating Extracorporeal Membrane Oxygenation in Patients With SevereCoronavirus Disease 2019 Pneumonia.

https://doi.org/10.1097/CCM.0000000000004560

なし

http://dx.doi.org/10.21037/atm-20-5334

あり

https://doi.org/10.11197/jaih.35.89

なし

https://doi.org/10.1016/j.gene.2020.145145

あり

https://doi.org/10.1186/s41232-020-00144-5あり

https://doi.org/10.11236/jph.20-069あり

https://doi.org/10.1016/j.jiac.2020.09.006あり

https://doi.org/10.1093/cid/ciaa1470

あり

https://doi.org/10.35772/ghm.2020.01061

なし

https://doi.org/10.1056/NEJMc2027051

あり

https://doi.org/10.1111/pcn.13161

あり

Crit Care Med. 2020;48(12):e1357-e1358.
Karako K, Song P, Chen Y, Tang W.
51

2020/8/24

Shifting workstyle to teleworking as a new normal in face of COVID-19: analysis with the model introducing intercity
movement and behavioral pattern.
Ann Transl Med. 2020;8(17):1056.
勝間靖

52

2020/9/23

COVID-19の大学生への影響：日本における外国人学生を中心に
国際保健医療.2020.35（2）：89-91.
Sugiyama M, Kinoshita N, Ide S, Nomoto H, Nakamoto T, Saito S, Ishikane M, Kutsuna S, Hayakawa K, Hashimoto M,
Suzuki M, Izumi S, Hojo M, Tsuchiya K, Gatanaga H, Takasaki J, Usami M, Kano T, Yanai H, Nishida N, Kanto T, Sugiyama

53

2020/9/14

H, Ohmagari N, Mizokami M.
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease inpatients with COVID-19.
Gene. 2020;766:145145.
Nakatani H, Katsuno K, Urabe H.

54

2020/9/15

Global health landscape challenges triggered by COVID-19.
Inflamm Regen. 2020;40:34.
杉山 雄大, 今井健二郎, 東 尚弘, 冨尾 淳, 田宮菜奈子.

55

2020/9/15

COVID-19後の公衆衛生対応の強化に向けて：米国 CDC の概説と日本版 CDC 構想への論点整理
日本公衛誌. 2020. 67(9): 567-572.
Suzuki T, Hayakawa K, Ainai A, Iwata-Yoshikawa N, Sano K, Nagata N, Suzuki T, Wakimoto Y, Akiyama Y, Miyazato Y,
Nakamura K, Ide S, Nomoto H, Nakamoto T, Ota M, Moriyama Y, Sugiki Y, Saito S, Morioka S, Ishikane M , Kinoshita N,

56

2020/9/9

Kutsuna S, Ohmagari N.
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection
among healthcare workers.
J Infect Chemother. 2021;27(1):120-122.
Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Asai Y, Tsuzuki S, Suzuki S, Toyoda A, Suzuki K, Endo M, Fujii N, Suzuki

58

2020/9/28

M, Saito Sho, Uemura Y, Shibata T, Kondo M, Izumi K, Terada-Hirashima J, Mikami A, Sugiura W, Ohmagari N.
Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN.
Clin Infect Dis. 2020:ciaa1470.
Indri Hapsari Susilowati, Hiroki Nakatani, Susiana Nugraha, Supa Pengpid, Wonpen Keawpan, Bonardo Prayogo Hasiholan,
Nguyen Phuong Toai, Ameerali Abdeali, Marzuki Isahak, Sudijanto Kamso.

57

2020/9/6

COVID-19 handling report for pre-case, case (pre-hospital and hospital), and post-case phases in the elderly as vulnerable
populations in 6 Asia Pacific countries.
Glob Health Med. 2020;2(6):350-359.
Kutsuna S, Asai Y, Matsunaga A.

60

2021/9/23

Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.
N Engl J Med. 2020;383(17):1695-1696.
Xiang M, Yamamoto S, Mizoue T.

59

2020/9/30

Depressive symptoms in students during school closure due to COVID-19 in Shanghai.
Psychiatry Clin Neurosci. 2020;74(12):664-666.
Takaya S, Tsuzuki S, Hayakawa K, Kawashima A, Okuhama A, Kanda K, Suzuki T, Akiyama Y, Miyazato Y, Ide S, Nakamura
K, Nomoto H, Nakamoto T, Hikida S, Tanuma J, Ohara K, Ito T, Baba T, Yamamoto K, Ujiie M, Saito S, Morioka S, Ishikane

61

2020/10/13

M, Kinoshita N, Kutsuna S, Ohmagari N.
Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.

https://doi.org/10.1017/S0950268820002496

あり

Epidemiol Infect. 2020;148:e250.
Nakamura K, Morioka S, Kutsuna S, Iida S, Suzuki T, Kinoshita N, Suzuki T, Sugiki Y, Okuhama A, Kanda K, Wakimoto Y,
Ujiie M, Yamamoto K, Ishikane M, Moriyama Y, Ota M, Nakamoto T, Ide S, Nomoto H, Akiyama Y, Miyazato Y, Hayakawa K,
62

2020/10/13

Saito S, Ohmagari N.
Environmental surface and air contamination in severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient

https://doi.org/10.1016/j.infpip.2020.100098

あり

https://doi.org/10.1016/j.ijid.2020.10.029あり

https://doi.org/10.1093/ofid/ofaa507

あり

https://doi.org/10.1002/jgf2.394

なし

rooms by disease severity.
Infection Prevention in Practice. 2020;2(4):100098.
Nakamoto T, Ishikane M, Sasaki R, Ohmagari N.
63

2020/10/17

Periungual desquamation in a Japanese Adult recovering from severe COVID-19.
Int J Infect Dis. 2020;102:37-39.
Miyazato Y, Morioka S, Tsuzuki S, Akashi M, Osanai Y, Tanaka K, Terada M, Suzuki M, Kutsuna S, Saito S, Hayakawa K,

64

2020/10/21

Ohmagari N.
Prolonged and late-onset symptoms of coronavirus disease 2019.
Open Forum Infectious Diseases. 2020;7(11):ofaa507.
Abe T, Tokuda Y, Iriyama H, Iwagami M, Komori A, Sugiyama T, Tamiya N.

65

2020/10/26

Surgical mask use by healthcare personnel to prevent COVID-19 spread in a long-term care facility.
J Gen Fam Med. 2020;26;22(2):100-103.
Ide S, Morioka S, Inada M, Ohmagari N.

66

2020/11/2

https://doi.org/10.2169/internalmedicine.6112-

Beau’s lines and leukonychia in a patient with coronavirus disease.

20

Intern Med. 2020;59(24):3259.

3あり2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/j.jinf.2020.10.033あり

https://doi.org/10.2196/23830

あり

Saito S, Asai Y, Matsunaga N, Hayakawa K, Terada M, Ohtsu H, Tsuzuki S, Ohmagari N.
67

2020/11/2

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics.
J Infect. 2021;82(4):84-123.
Terada-Hirashima J, Suzuki M, Uemura Y, Hojo M, Mikami A, Sugiura W, Ohmagari N, Sugiyama H.

70

2020/11/18

The RACCO Trial to Assess the Efficacy and Safety of Inhaled Ciclesonide for Asymptomatic and Mild Patients with Covid19: A Study Protocol for a Multi-center, Open- labeled, Randomized Controlled Trial.
JMIR Res Protoc. 2020;9(12):e23830.
Akiyama Y, Morioka S, Wakimoto Y, Kawashima A, Kanda K, Okuhama A, Suzuki T, Miyazato Y, Nomoto H, Ide S, Nakamoto
T, Nakamura K, Ota M, Moriyama Y, Takaya S, Yamada K, Taguchi M, Sugito E, Izuka S, Ishiguro K, Kobayashi T, Miyake

69

2020/11/2

W, Kubota S, Ishikane M, Kinoshita N, Yamamoto K, Ujiie M, Kutsuna S, Hayakawa K, Saito S, Ohmagari N.
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-Center, Observational Study inhttps://doi.org/10.2169/internalmedicine.561420

あり

Tokyo, Japan.
Intern Med. 2020;59(24):3131-3133.
Hayama H, Ishikane M, Sato R, Kanda K, Kinoshita N, Izumi S, Ohmagari N, Hiroi Y.
68

2020/11/5

Association of plain computed tomography-determined pulmonary artery-to-aorta ratio with clinical severity of coronavirus
disease 2019.

https://doi.org/10.1177/2045894020969492

あり

https://doi.org/10.1111/1744-9987.13608

あり

https://doi.org/10.35772/ghm.2020.01085

あり

https://doi.org/10.1186/s41182-020-00281-0あり

https://doi.org/10.35772/ghm.2020.01091

あり

https://doi.org/10.1002/jca.21861

あり

https://doi.org/10.1016/j.jiac.2020.12.011

あり

https://doi.org/10.1016/j.ijid.2020.12.079

あり

Pulmonary Circulation. 2020;10(4):2045894020969492.
Arai Y, Katagiri D, Hinoshita F.
71

2020/11/15

A case of dialysis interruption caused by voluntary quarantine against the coronavirus disease (COVID-19) after returningfrom overseas to Japan.
Ther Apher Dial. 2021;25(5):704-705.
Osanai Y, Kinoshita N, Hayakawa K, Tanaka K, Hamano T, Kutsuna S, Ujiie M, Morioka S, Yamamoto K, Isikane M, Saito

72

2020/11/16

Sho, Sugiura Y, Ohmagari .
Telephone consults at the Infectious Disease Outpatient Clinic during the early period of the COVID-19 epidemic.
Glob Health Med. 2020;2(6):392-394.
Fujita M, Matsuoka S, Kiyohara H, Kumakura Y, Takeda Y, Goishi N, Tarui M, Inaba M, Nagai M, Hachiya M, Fujita N.

73

2020/11/23“Staying at home” to tackle COVID-19 pandemic: Rhetoric or Reality?Cross-cutting analysis of nine population groups
vulnerable to homelessness in Japan.
Trop Med Health. 2020; 48(1):92.
Yashiro S, Ueta T, Kutsuna S, Okamoto T, Nagahara M, Ohmagari N.

74

2020/12/14

Using flowchart for ophthalmic consultations in hospitalized patients with COVID-19.
Glob Health Med. 2020;2(6):395-397.
Katagiri D, Ishikane M, Asai Y, Izumi S, Takasaki J, Katsuoka H, Kondo I, Ide S, Nakamura K, Nakamoto T, Nomoto H,
Akiyama Y, Miyazato Y, Suzuki T, Kinoshita N, Ogawa T, Togano T, Suzuki M, Hashimoto M, Sakamoto K, Kusaba Y,

75

2020/12/15

Katsuno T, Fukaya T, Hojo M, Sugiyama M, Mizokami M, Okamoto T, Kimura A, Noiri E, Ohmagari N, Hinoshita F, Sugiyama
H.
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19.
J Clin Apher. 2021;36(3):313-321.
Asai Y, Tsuzuki S, Kutsuna S, Hayakawa K, Ohmagari N.

76

2020/12/16

Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection:
A modelling study.
J Infect Chemother. 2021;27(3):515-520.
Yamamoto K, Suzuki M, Yamada G, Sudo T, Nomoto H, Kinoshita N, Nakamura K, Tsujimoto Y, Kusaba Y, Morita C, Moriya
A, Maeda K, Yagi S, Kimura M, Ohmagari N.

77

2020/12/26

Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of diseasetransmission.
Int J Infect Dis. 2021;104:65-72.
Sato L, Kinoshita N, Nakamoto T, Ohmagari N.

78

2021/1/15

Hemoptysis and a Newly Formed Lung Bulla in a Case of Convalescent COVID-19 Pneumonia.
Intern Med. 2021;60(5):803-805.

https://doi.org/10.2169/internalmedicine.568420

あり

Nomoto H, Kutsuna S, Okuma K, Kuramitsu M, Tezuka K, Ikebe E, Saito S, Kinoshita N, Terada M, Endo M,
79

2021/1/10

Suzuki T, Miyazato Y, Nakamoto T, Inada M, Hamaguchi I, Ohmagari N.
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity.

https://doi.org/10.1016/j.jiac.2021.01.004あり

https://doi.org/10.1056/NEJMoa2031994

なし

J Infect Chemother. 2021;27(4):653-655.
Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S,
Tapson V, Iovine NM, Jain MK, Sweeney DA, El Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U,
Luetkemeyer AF, Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Erdmann N, Ahuja N, Frank M,
Oh MD, Kim ES, Tan SY, Mularski RA, Nielsen H, Ponce PO, Taylor BS, Larson L, Rouphael NG, Saklawi Y, Cantos VD, Ko
80

2020/12/11

ER, Engemann JJ, Amin AN, Watanabe M, Billings J, Elie MC, Davey RT, Burgess TH, Ferreira J, Green M, Makowski M,
Cardoso A, de Bono S, Bonnett T, Proschan M, Deye GA, Dempsey W, Nayak SU, Dodd LE, Beigel JH; ACTT-2 Study Group
Members.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med. 2021;384(9):795-807.
氏家無限,加藤康幸,黒木淳,寺島俊和,伊藤稔之,麻岡大裕,白野倫徳,柿木康孝. 新型コロナウイルスのPCR検査が退院後に再陽性

812020/11/9となった4 例の報告.

http://journal.kansensho.or.jp/Disp?style=abst&
vol=95&mag=0&number=1&start=32

感染症誌. 2021;95:32-36.

あり

Kutsuna S, Asai Y, Matsunaga A, Kinoshita N, Terada M, Miyazato Y, Nakamoto T, Suzuki T, Saito S, Endo M, Kanda K,
82

2021/1/18

Kenji M, Takasaki J, Hojo M, Ishizaka Y, Ohmagari N.
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.

https://doi.org/10.1016/j.jiac.2021.01.006あり

https://doi.org/10.1007/s11606-020-06413-w

なし

https://doi.org/10.1097/mat.0000000000001402

あり

https://doi.org/10.3390/ijerph18031148

あり

https://doi.org/10.1016/j.jinf.2021.01.010

あり

https://doi.org/10.1016/j.gene.2021.145496

あり

J Infect Chemother. 2021;27(6):808-813.
Ikesu R, Miyawaki A, Sugiyama T, Nakamura M, Ninomiya H, Kobayashi Y.
83

2021/1/19

Trends in Diabetes Care during the COVID-19 Outbreak in Japan: an Observational Study.
J Gen Intern. 2021;36(5):1460-1462.
Ogawa T, Uemura T, Matsuda W, Sato M, Ishizuka K, Fukaya T, Kinoshita N, Nakamoto T, Ohmagari N, Katano H, Suzuki T,

84

2021/1/21

Hosaka S.
SARS-CoV-2 Leakage from the Gas Outlet Port during Extracorporeal Membrane Oxygenation for COVID-19.
ASAIO J. 2021;67(5):511-516.
Ito T, Hirata-Mogi S, Watanabe T, Sugiyama T, Jin X, Kobayashi S, Tamiya N.

852021/1/28

Change of Use in Community Services among Disabled Older Adults during COVID-19 in Japan.
Int J Environ Res Public Health. 2021;18(3):1148.
Tanaka A, Yamamoto S, Miyo K, Mizoue T, Maeda K, Sugiura W, Mitsuya H, Sugiyama H, Ohmagari N. Seroprevalence of86

2021/1/29

antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan.
J Infect. 2021;82(4):e1-e3.
Hoshino K, Maeshiro T, Nishida N, Sugiyama M, Fujita J, Gojobori T, Mizokami M.

87

2021/2/3

Transmission dynamics of SARS-CoV-2 on the Diamond Princess uncovered using viral genome sequence analysis.
Gene 2021;779:145496.
Sakamoto H, Ishikane M, Ghaznavi C, Ueda P.

902021/2/2

Assessment of Suicide in Japan During the COVID-19 Pandemic vs Previous Years.
JAMA Netw Open. 2021;1;4(2):e2037378.

4https://doi.org/10.1001/jamanetworkopen.2020.3
7378

なし

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1111/pcn.13206

あり

https://doi.org/10.5582/bst.2021.01019

あり

https://doi.org/10.1038/s41467-021-20900-6あり

https://doi.org/10.35772/ghm.2020.01106

あり

https://doi.org/10.35772/ghm.2020.01093

あり

https://doi.org/10.35772/ghm.2020.01119

あり

https://doi.org/10.35772/ghm.2020.01109

あり

https://doi.org/10.7883/yoken.JJID.2020.813あり

https://doi.org/10.35772/ghm.2020.01081

あり

https://doi.org/10.35772/ghm.2020.01117

あり

https://doi.org/10.1038/s41598-021-84733-5あり

https://doi.org/10.1080/23744235.2021.1903550

あり

https://doi.org/10.1016/j.idcr.2021.e01094

あり

https://doi.org/10.1016/j.resinv.2021.02.011

あり

https://doi.org/10.1002/1348-9585.12213

なし

https://doi.org/10.1136/bmjopen-2021-049996

あり

https://doi.org/10.35772/ghm.2021.01022

あり

Miki T, Yamamoto S, Inoue Y, Fukunaga A, Islam Z, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
89

2021/1/28

Association between living with others and depressive symptoms in Japanese hospital workers during the COVID-19
pandemic.
Psychiatry Clin Neurosci. 2021;75(4):148-149.
Karako K, Song P, Chen Y, Tang W, Kokudo N.

88

2021/1/29

Overview of the characteristics of and responses to the three waves of COVID-19 in Japan during 2020-2021.
Biosci Trends. 2021;15(1):1-8.
Hattori SI, Higashi-Kuwata N, Hayashi H, Allu SR, Raghavaiah J, Bulut H, Das D, Anson BJ, Lendy EK, Takamatsu Y,
Takamune N, Kishimoto N, Murayama K, Hasegawa K, Li M, Davis DA, Kodama EN, Yarchoan R, Wlodawer A, Misumi S,

91

2021/1/28

Mesecar AD, Ghosh AK, Mitsuya H.
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Nat Commun. 2021;12(1):668.
Saito S, Hayakawa K, Mikami A, Izumi S, Funazaki H, Ashida S, Sugiura W, Sugiyama H, Kokudo N, Ohmagari N.

92

2021/2/11

Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan.
Glob Health Med. 2021;3(2):62-66.
Fujita M, Umeda T, Fujita N, Nishioka T, Iwamoto A, Ohmagari N, Ishikane M, Akashi H, Kokudo Norihiro.

93

2021/2/11

Japanese WHO Collaborating Centres (WHO CCs) fight against COVID-19.
Glob Health Med. 2021;3(2):115-118.
Tomidokoro D, Hayama H, Okazaki T, Hara H, Hiroi Y.

94

2021/2/15

The effect of the COVID-19 pandemic on incidence and characteristics of pulmonary embolism.
Glob Health Med. 2021;3(2):122-124.
Norizuki M, Hachiya M, Motohashi A, Moriya A, Mezaki K, Kimura M, Sugiura W, Akashi H, Umeda T.

96

2021/3/9

Effective screening strategies for detection of asymptomatic COVID-19 travelers at airport quarantine stations: Exploratory
findings in Japan.
Glob Health Med. 2021;3(2):107-111.
Ide S, Hayakawa K, Yamamoto K, Tsuzuki S, Tanuma J, Ohara K, Yamada G, Okuhama A, Kanda K, Suzuki T, Akiyama Y,
Miyazato Y, Nakamura K, Nomoto H, Nakamoto T, Ujiie M, Saito S, Morioka S, Ishikane M, Kinoshita N, Kutsuna S, Tanaka

95

2021/2/26

K, Ohmagari N.
Positive ratio of polymerase chain reaction (PCR) and validity of pre-screening criteria at an outpatient screening center
during the early phase of the COVID-19 epidemic in Japan.
Jpn J Infect Dis. 2021;74(5):481-486.
Usami M, Sasaki S, Sunakawa H, Toguchi Y, Tanese S, Saito K, Shinohara R, Kurokochi T, Sugimoto K,
Itagaki K, Yoshida Y, Namekata S, Takahashi M, Harada I, Hakoshima Y, Inazaki K, Yoshimura Y, Mizumoto

97

2021/3/6

Y.
Care for children's mental health during the COVID-19 pandemic in Japan.
Glob Health Med. 2021;3(2):119-121.
Hojo M, Terada-Hirashima J, Sugiyama H.

98

2021/3/9

COVID-19 and bronchial asthma: current perspectives.
Glob Health Med. 2021;3(2):67-72.
Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori SI, Kouki Matsuda , Takamatsu Y, Gatanaga H,

992021/3/10

Oka S, Sugiyama H, Ohmagari N, and Mitsuya H.
Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma.
Sci Rep. 2021;11(1):5563.
Tsujimoto Y, Terada J, Kimura M, Moriya A, Motohashi A, Izumi S, Kawajiri K, Hakkaku K, Morishita M, Saito S, Takumida
H, Watanabe H, Tsukada A, Morita C, Yamaguchi Y, Katsuno T, Kusaba Y, Sakamoto K, Hashimoto M, Suzuki M, Takasaki

100

2021/3/24

J, Hojo M, Miyoshi-Akiyama T, Sugiyama H.
Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using
RT-PCR.
Infect Dis (Lond). 2021;53(8):581-589.
Miyazato Y, Ishikane M, Inada M, Ohmagari N.

102

2021/3/27

Acute portal vein thrombosis with COVID-19 and cirrhosis.
IDCases. 2021;24:e01094.
Katsuno T, Suzuki M, Hojo M, Terada J, Nakamura K, Suzuki T, Miyazato Y, Sugiyama H.

101

2021/3/26

Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan.
Respir Invest. 2021;59(4):569-572.
Morishita K, Takase K, Ishikane M, Otomo Y.

103

2021/3/31

Impact of incentives for health-care workers wearing personal protective equipment while dealing with coronavirus diseasein Japan.
J Occup Health. 2021;63(1):e12213.
Inoue Y, Yamamoto S, Fukunaga A, Hoang DV, Miki T, Islam Z, Miyo K, Ishii M, Ishiwari H, Konishi M, Ohmagari N, MizoueT.

1042021/4/1

Association between engagement in COVID-19-related work and depressive symptoms among hospital workers in adesignated COVID-19 hospital in Japan: a cross-sectional study.
BMJ Open. 2021;11(4):e049996.
Yamamoto S, Tanaka A, Kobayashi S, Oshiro Y, Ozeki M, Maeda K, Matsuda K, Miyo K, Mizoue T, Sugiura W, Mitsuya H,
Sugiyama H, Ohmagari N.

105

2021/4/2

Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospitalin Tokyo, Japan.
Glob Health Med. 2021;3(2):90-94.
Yamamoto K, and Ohmagari N.

106

2021/4/2

https://www.jmaj.jp/detail.php?id=10.31662%2Fj

Microbiological Testing for Coronavirus Disease 2019.

maj.2021-0012

JMA Journal. 2021;4(2):67-75.

あり

Hayama H,Ide Satoshi , Moroi M, Kitami Y, Bekki N, Kubota S, Uemura Y, Hara H, Kutsuna S, Ohmagari N, Hiroi Y.
1072021/4/2

Elevated high-sensitivity troponin is associated with subclinical cardiac dysfunction in patients recovered from coronavirus
disease 2019.

https://doi.org/10.35772/ghm.2021.01025

あり

https://doi.org/10.1002/eahr.500089

なし

https://doi.org/10.35772/ghm.2020.01107

あり

https://doi.org/10.35772/ghm.2021.01031

あり

https://doi.org/10.1111/jog.14377

あり

Glob Health Med. 2021;3(2):95-101.
Matsui K, Inoue Y, Yamamoto K.
108

2021/4/6

SARS-CoV-2 Human Challenge Trials: Rethinking the Recruitment of Healthy Young Adults First.
Ethics Hum Res. 2021;43(3):37-41.
Kono Y, Shimizu E, Matsunaga F, Egami Y, Yoneda K, Sakamoto K, Mubita M, Sichizya V S , Wakamatsu K, Terashima M,
Fujita N.

110

2021/2/18

Enhancing the use of computed tomography and cardiac catheterizationangiography in Zambia: A project report on a global
extension ofmedical technology in Japan.
Glob Health Med. 2021;3(1):52-55.
Kokudo N, Sugiyama H.

109

2021/4/11

Hospital capacity during the COVID-19 pandemic.
Glob Health Med. 2021;3(2):56-59.
Kikuchi S, Komagata T, Obara H.

111

2020/8/7

Do the Asia and Oceania Federation of Obstetrics and Gynecology members' websites provide information targeting
women in the context of the COVID‐19 pandemic?
J Obstet Gynaecol Res. 2020;46(10):2193-2194.

52024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1177%2F10105395211007604

あり

Fukunaga A, Inoue Y, Yamamoto S, Miki T, Nanri A, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.
112

2021/4/8

Association Between Adherence to Healthy Lifestyles and Depressive Symptoms Among Japanese Hospital Workers
During the COVID-19 Pandemic.
Asia Pac J Public Health. 2021;33(8):847-853.
守屋任, 山元佳, 秋山徹, 木下典子, 須藤務, 本橋亜耶乃, 宇佐見彩香, 猪坂英里奈, 安藤ほなみ, 大木仁, 黒川正美, 目崎和久, 田中
暁人, 荘司路, 小関満, 木村基, 大曲貴夫.

113

2020/11/11

鼻咽頭ぬぐい液を対象とした新型コロナウイルス遺伝子検出POCT試薬「スマートジーン新型コロナウイルス検出試薬」の検討.

http://journal.kyorin.co.jp/journal/jscm/detail_j.p
hp?-DB=jscm&-recid=1152&-action=browseあり

日本臨床微生物学会雑誌. 2021;31(2):103-107
Suzuki T, Kutsuna S, Saito S, Kawashima A, Okuhama A, Kanda K, Sato L, Inada M, Akiyama Y, Ide S, Nakamura K,
114

2021/5/4

Nakamoto T, Yamamoto K, Ishikane M, Kinoshita N, Morioka S, Hayakawa K, Ohmagari N.
Clinical course of alopecia after COVID-19.

https://doi.org/10.1016/j.ijid.2021.04.088あり

https://doi.org/10.1016/j.jiac.2021.04.008

あり

https://doi.org/doi: 10.31662/jmaj.2021-0013

あり

Int J Infect Dis. 2021;107:255-256.
Yamada G, Hayakawa K, Asai Y, Matsunaga N, Ohtsu H, Hojo M, Hashimoto M, Kobayashi K, Sasaki R, Okamoto T,
Yanagawa Y, Katagiri D, Terada M, Suzuki M, Sato L, Miyazato Y, Ishikane M, Morioka S, Saito S, Ohmagari N.
115

2021/4/12

External validation and update of prediction models for unfavorable outcomes in hospitalized patients with COVID-19 inJapan.
J Infect Chemother. 2021;27(7):1043-1050.
Kutsuna S.

116

2021/4/15

Clinical Manifestations of Coronavirus Disease 2019.
JMA J. 2021;4(2):76-80.
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S,
Ishizaka Y, Mitsuya H, Ohmagari N.

117

2021/4/24

Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of
neutralizing antibodies.

https://www.jiac-j.com/article/S1341321X(21)00124-0/pdf

あり

J Infect Chemother. 2021;27(7):1063-1067.
Kobayashi J, Aritaka N, Nozaki I, Tabata A, Noda S.
118

2021/5/7

COVID-19 control during a humanitarian crisis; the need for emergency response at the Thai-Myanmar border as analternative channel.

https://doi.org/doi: 10.1186/s41182-021-00323-1

なし

https://doi.org/10.1016/j.jiac.2021.05.006

あり

https://doi.org/10.1253/circj.CJ-21-0219

あり

https://doi.org/10.1016/j.jinf.2021.05.017

あり

Trop Med Health. 2021;49(1):33.
Yamamoto K, Nagashima M, Yoshida I, Sadamasu K, Kurokawa M, Nagashima M, Kinoshita N, Maeda K, Takasaki J,
1192021/5/12

Teruya K, Ohmagari N.
Does the SARS-CoV-2 rapid antigen test result correlate with the viral culture result?
J Infect Chemother. 2021;27(8):1273-1275.
Ide S, Hayama H, Asai Y, Terada M, Nomoto H, Kutsuna S, Ohmagari N, Hiroi Y.

1202021/5/15

Evaluation of High-Sensitivity Cardiac Troponin T Levels in Japanese Patients Recently Recovered From Coronavirus
Disease 2019.
Circ J. 2021;85(6):944-947.
Yamamoto S, Tanaka A, Oshiro Y, Ishii M, Ishiwari H, Konishi M, Matsuda K, Ozeki M, Miyo K, Maeda K, Mizoue T, Sugiura
W, Mitsuya H, Sugiyama H, Ohmagari N.

121

2021/5/25

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave ofJapan.
J Infect. 2021;83(2):237-279.
Tsukada A, Suzuki M, Kishino Y, Misumi K, Igari T, Nakajima N, Sato Y, Suzuki T, Katsuno T, Kusaba Y, Tsujimoto Y,
Sakamoto K, Hashimoto M, Terada J, Takasaki J, Izumi S, Hojo M, Sugiyama H.

122

2021/5/29

A Kidney Transplant Patient Who Died of COVID-19-associated Severe Acute Respiratory Distress Syndrome: A Case
Report.

https://doi.org/10.2169/internalmedicine.708921

あり

Intern Med. 2021;60(14):2297-2300.
Akiyama Y, Kinoshita N, Sadamasu K, Nagashima M, Yoshida I, Kusaba Y, Suzuki T, Nagashima M, Ishikane M, Takasaki J,
123

2021/5/31

Yoshimura K, Ohmagari N.
A pilot study of viral load in stools of patients with COVID-19 and diarrhea.

https://doi.org/10.7883/yoken.JJID.2021.018あり

https://doi.org/10.1111/trf.16541

あり

https://doi.org/10.1136/bmjopen-2020-047007

あり

https://doi.org/10.35772/ghm.2021.01066

あり

https://doi.org/10.35772/ghm.2021.01076

あり

https://doi.org/10.5582/bst.2021.01263

あり

https://doi.org/10.35772/ghm.2021.01062

あり

https://doi.org/10.1016/j.jiac.2021.07.002あり

https://doi.org/10.1016/j.jiac.2021.07.016

あり

https://doi.org/10.3820/jjpe.26.91

あり

https://doi.org/10.1017/S0950268821001837

あり

Jpn J Infect Dis. 2021.
Terada M, Kutsuna S, Togano T, Saito S, Kinoshita N, Shimanishi Y, Suzuki T, Miyazato Y, Inada M, Nakamoto T, Nomoto
H, Ide S, Sato M, Maeda K, Matsunaga A, Satake M, Matsubayashi K, Tsuno H, Kojima M, Kuramistu M, Tezuka K, Ikebe E,
1242021/6/7

Okuma K, HamTerada Maguchi I, Shiratori K, Sato M, Kawakami Y, Inaba K, Igarashi S, Yamauchi R, Matsumura M,
Ishimaru K, Zhang B, Kuge C, Ishihara M, Gouda M, Tanaka K, Ishizaka Y, Ohmagari N.
How we secured a COVID-19 convalescent plasma procurement scheme in Japan.
Transfusion. 2021;61(7):1998-2007.
Terada M, Ohtsu H, Saito S, Hayakawa K, Tsuzuki S, Asai Y, Matsunaga N, Kutsuna S, Sugiura W, Ohmagari N.

125

2021/6/15

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with
COVID-19 in Japan.
BMJ Open. 2021;11(6):e047007.
Sawakami T, Karako K, Song P.

126

2021/6/25

Behavioral changes adopted to constrain COVID-19 in Japan: What are the implications for seasonal influenza prevention
and control?
Glob Health Med. 2021;3(3):125-128.
Minamimoto R, Kiyomatsu T.

127

2021/6/27

Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.
Glob Health Med. 2021;3(3):129-133.
Qi F, Tang W.

128

2021/7/1

Traditional Chinese medicine for treatment of novel infectious diseases: Current status and dilemma.
Biosci Trends. 2021;15(4):201-204.
Ito K, Takemura N, Hasegawa K, Kokudo N.

129

2021/7/5

COVID-19 and liver surgery in France, Italy, Japan, and the United States: A report of a single topic conference of Easternand Western Association for Liver Tumors (EWALT) 2021.
Glob Health Med. 2021;3(4):240-242.
Okuhama A, Ishikane M, Hotta M, Sato L, Akiyama Y, Morioka S, Suzuki S, Tajima T, Yamamoto M, Teruya K, Izumi S,

130

2021/7/13

Ohmagari N.
Clinical and radiological findings of silent hypoxia among COVID-19 patients.
J Infect Chemother. 2021;27(10):1536-1538.
Togano T, Uemura Y, Asai Y, Hayakawa K, Matsunaga N, Terada M, Ohtsu H, Suzuki S, Toyoda A, Hara H, Sato R, Ishikane
M, Kinoshita-Iwamoto N, Hangaishi A, Ohmagari N.

131

2021/7/24

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with
COVID-19 in Japan.
J Infect Chemother. 2021;27(10):1498-1503.
杉浦 亙

132

2021/7/26

出口戦略としての SARS-CoV-2 治療薬・ ワクチン開発の現状と課題.
薬剤疫学. 2021;26(1):91-97.
Yamada G, Hayakawa K, Matsunaga N, Terada M, Suzuki S, Asai Y, Ohtsu H, Toyoda A, Kitajima K,
Tsuzuki S, Saito, Ohmagari N.

133

2021/7/30

Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for
hospitalisation.
Epidemiol Infect. 2021, e175.

62024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1093/cid/ciab689

なし

https://doi.org/10.5582/bst.2021.01269

あり

https://doi.org/10.1093/cid/ciab659あり

https://doi.org/10.3201/eid2711.211565

あり

https://doi.org/10.35772/ghm.2021.01092

あり

https://doi.org/10.1016/j.lanwpc.2020.100030

なし

https://doi.org/10.1371/journal.pone.0256441

あり

https://doi.org/10.35772/ghmo.2021.01025

なし

https://doi.org/10.1111/ped.14981

なし

https://doi.org/10.1093/jpids/piab085あり

https://doi.org/10.1016/j.ijid.2021.09.014あり

https://doi.org/10.7883/yoken.JJID.2021.416あり

https://doi.org/10.1016/j.jiac.2021.08.015あり

Banno M, Tsujimoto Y, Ishikane M.
1342021/8/6

Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for
the treatment of coronavirus disease.
Clin Infect Dis. 2021.
Sawakami T, Karako K, Song P, Sugiura W, Kokudo N.

135

2021/7/13

Infectious disease activity during the COVID-19 epidemic in Japan: Lessons learned from prevention and control measures.
Biosci Trends. 2021;15(4):257-261.
Tsuboi M, Hachiya M, Ohtsu H, Akashi H, Miyoshi C, Umeda T.

136

2021/7/28

Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide
descriptive analysis and an individually matched case-control study.
Clin Infect Dis. 2021;ciab659.
Ujiie M, Tsuzuki S, Nakamoto T, Iwamoto N.

137

2021/8/13

Resurgence of Respiratory Syncytial Virus Infections during COVID-19 Pandemic, Tokyo, Japan.
Emerg Infect Dis. 2021;27(11):2969-2970.
Hikida S, Morioka S, Fujii N, Tajima T, Terayama Y, Sugiura Y, Ishikane M, Takasaki J, Hojo M, Ohmagari N.

138

2021/8/9

A single-center descriptive study of untraced sources of infection among new cases of coronavirus disease in Tokyo,
Japan.
Glob Health Med. 2021;3(4):236-239.
Tsuzuki S.

139

2020/9/23

Evaluation of non-pharmaceutical factors determine transmissibility of COVID-19: Useful insights and future challenges.
Lancet Reg Health West Pac. 2020;3:100030.
Hoang DV, Yamamoto S, Miki T, Fukunaga A, Islam Z, Konishi M, Mizoue T.

140

2021/8/27

Is there an association between ABO blood types and depressive symptoms among Japanese healthcare workers during
the COVID-19 pandemic?
PLoS One. 2021;16(8):e0256441.
Isaka Y, Hori A, Tabuchi T, Okawa S, Ichikawa M.

141

2021/7/21

Home-visit services for the families with newborns during the COVID-19 pandemic.
GHM Open. 2021;1(1):38-39.
Hangai M, Piedvache A, Sawada N, Okubo Y, Sampei M, Yamaoka Y, Tanaka K, Hosozawa M, Morisaki N, Igarashi T.

1422021/9/4

Children’s Daily Lives and Well-being: Findings from the CORONA-CODOMO Survey #1.
Pediatr Int. 2021.
Shoji K, Akiyama T, Tsuzuki S, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Ohmagari N.

143

2021/9/6

Clinical Characteristics of Hospitalized COVID-19 in Children: Report From the COVID-19 Registry in Japan.
J Pediatric Infect Dis Soc. 2021.
Hara H, Uemura Y, Hayakawa K, Togano T, Asai Y, Matsunaga N, Terada M, Ohtsu H, Kitajima K, Shimizu Y, Sato L,
Ishikane M, Kinoshita-Iwamoto N, Shibata T, Kondo M, Izumi K, Sugiura W, Ohmagari N. Evaluation of the efficacy of

144

2021/9/6

anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease inJapan.
Int J Infect Dis. 2021.
Motohashi A, Yamamoto K, Mezaki K, Moriya A, Kurokawa M, Oki H, Ando H, Isaka E, Usami A, Ide S, Nakamura K,
Nakamoto T, Nomoto H, Ohmagari N.

145

2021/9/30

Negative Results of Nucleic Acid Amplification Test for SARS-CoV-2 in Clinical Practice May Vary among Six Molecular
Assays in COVID-19 Patients.
Jpn J Infect Dis. 2021
Nomoto H, Yamamoto K, Yamada G, Suzuki M, Kinoshita N, Takasaki J, Moriya A, Maeda K, Kimura M, Ohmagari N. Time-146

2021/8/14

course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential
contribution to alleviating isolation of COVID-19 patients.
J Infect Chemother. 2021;27(11):1669-1673.
Ishiguro T, Kobayashi Y, Shimizu Y, Uemura Y, Isono T, Takano K, Nishida T, Kobayashi Y, Hosoda C, Takaku Y, Shimizu Y,

1482021/9/18

Takayanagi N.

https://doi.org/10.2169/internalmedicine.8021-

Frequency and Significance of Coinfection in Patients with COVID-19 at Hospital Admission.

21

なし

Intern Med. 2021.
Maruki T, Ishikane M, Suzuki T, Ujiie M, Katano H, Ohmagari N.
149

2021/9/26

A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetentpatient.

https://doi.org/10.1016/j.ijid.2021.09.055あり

https://doi.org/10.3201/eid2710.204685

なし

https://doi.org/10.1016/j.jjcc.2021.09.010

あり

https://doi.org/10.1007/s10461-021-03464-w

あり

https://doi.org/10.1128/mBio.01987-21あり

https://doi.org/10.1016/j.ijid.2021.09.070

なし

https://doi.org/10.3390/genes12101572

あり

https://doi.org/10.35772/ghm.2021.01090

あり

Int J Infect Dis. 2021;113:55-57.
Saito T, Muto K, Tanaka M, Okabe N, Oshitani H, Kamayachi S, Kawaoka Y, Kawana A, Suzuki M, Tateda K, Nakayama H,
Yoshida M, Imamura A, Ohtake F, Ohmagari N, Osaka K, Kaku M, Sunagawa T, Nakashima K, Nishiura H, Wada K, Omi S,
147

2021/9/8

Wakita T.
Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, FebruaryJune 2020.
Emerg Infect Dis. 2021;27(10):1-9.
Tomidokoro D, Hiroi Y.

150

2021/9/6

Cardiovascular implications of the COVID-19 pandemic.
Journal of Cardiology. 2021.
Matsumoto S, Nagai M, Luong DAD, Nguyen HDT, Nguyen DT, Van Dinh T, Van Tran G, Tanuma J, Pham TN, Oka S.

151

2021/9/27

Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky
Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam.
AIDS Behav. 2021
Maemura T, Kuroda M, Armbrust T, Yamayoshi S, Halfmann PJ, Kawaoka Y.

152

2021/9/28

Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but
Does Not Contribute to Aberrant Cytokine Production by Macrophages.
mBio. 2021;12(5):e0198721.
Tanaka H, Lee H, Morita A, Namkoong H, Chubachi S, Kabata H, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda
S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R, Kitagawa Y,

153

2021/9/30

Tokunaga K, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force.
Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19
Task Force, a Nation-wide Consortium to Investigate Host Genetics of COVID-19.
Int J Infect Dis. 2021.
Yamamoto N, Nishida N, Yamamoto R, Gojobori T, Shimotohno K, Mizokami M, Ariumi Y.

154

2021/10/1

Angiotensin–Converting Enzyme (ACE) 1 Gene Polymorphism and Phenotypic Expression of COVID‐19 Symptoms.
Genes 2021;12(10):1572.
Hayama H, Ide S, Kitami Y, Hara H, Kutsuna S, Hiroi Y.

155

2021/10/7

Interleukin-6 is upregulated and may be associated with myocardial injury in some patients who have recovered fromCOVID-19.
Glob Health Med. 2021.

7

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/j.jiac.2021.09.015

あり

https://doi.org/10.1016/S2213-2600(21)00384-2

なし

https://doi.org/10.1016/j.bbrc.2021.08.048あり

https://doi.org/10.3390/ijms22095000

あり

https://doi.org/10.4172/2476-2024.1000173

あり

https://doi.org/10.1016/j.jiac.2021.10.012あり

https://doi.org/10.1016/j.jiac.2021.10.013あり

https://doi.org/10.1016/j.jiac.2021.10.021

あり

https://doi.org/10.35772/ghmo.2021.01029

あり

https://doi.org/10.3390/v13112183

あり

https://doi.org/10.1186/s13063-021-05763-yなし

https://doi.org/10.1016/j.idcr.2021.e01343

あり

https://doi.org/10.1038/s41589-021-00923-2

なし

https://doi.org/10.35772/ghmo.2021.01030

あり

https://doi.org/10.1038/s41586-021-04266-9

掲載予定

https://doi.org/10.1016/j.resinv.2021.11.001あり

https://doi.org/10.1159/000521000

あり

https://doi.org/10.1007/s13730-021-00671-1

あり

https://doi.org/10.1093/ije/dyab254あり

https://doi.org/10.46234/ccdcw2021.254

掲載予定

Nomoto H, Ishikane M, Lee S, Komiya N, Maeki T, Matsui T, Morita K, Oshitani H, Saijo M, Yamagishi T, Yamamoto T,
Ohmagari N.
156

2021/10/8

Facilitating the deployment of Japanese human resources for responding global outbreaks of emerging and Re-emerging
infectious diseases: A cross-sectional study.
J Infect Chemother. 2021.
Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda
J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine NM, Tapson VF, Oh MD, Whitaker JA, Mularski RA, Paules CI, Ince D,
Takasaki J, Sweeney DA, Sandkovsky U, Wyles DL, Hohmann E, Grimes KA, Grossberg R, Laguio-Vila M, Lambert AA,
Lopez de Castilla D, Kim E, Larson L, Wan CR, Traenkner JJ, Ponce PO, Patterson JE, Goepfert PA, Sofarelli TA, Mocherla

1572021/10/18

S, Ko ER, Ponce de Leon A, Doernberg SB, Atmar RL, Maves RC, Dangond F, Ferreira J, Green M, Makowski M, Bonnett T,
Beresnev T, Ghazaryan V, Dempsey W, Nayak SU, Dodd L, Tomashek KM, Beigel JH; ACTT-3 study group members.
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: adouble-bind, randomised, placebo-controlled, phase 3 trial.
Lancet Respir Med. 2021.
Suzuki Y, Hishiki T, Emi A, Sakaguchi S, Itamura R, Yamamoto R, Matsuzawa T, Shimotohno K, Mizokami M, Nakano T,

158

2021/8/23

Yamamoto N.
Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria.
Biochem Biophys Res Commun. 2021;575:36-41.
Yamamoto N, Yamamoto R, Ariumi Y, Mizokami M, Shimotohno K, Yoshikura H.

159

2021/5/8

Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities andExplain the Huge Mortality Disparity between the East and the West?
Int J Mol Sci. 2021;22(9):5000.
Yamamoto N.

160

2020/9/14

COVID-19 and the Angiotensin-Converting Enzyme 1 D/I Genotype: Protection of People at High-Risk by Predicting the
Severity of the Disease.
Diagn Pathol Open 5: 173.
Suzuki T, Asai Y, Ide S, Fukuda S, Tanaka A, Shimanishi Y, Takahashi K, Terada M, Sato L, Sato M, Inada M, Yamada G,
Miyazato Y, Akiyama Y, Nomoto H, Nakamoto T, Nakamura K, Togano T, Morioka S, Kinoshita-Iwamoto N, Saito S,

161

2021/10/19

Kutsuna S, Ohmagari N.
Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A
single-center cross-sectional study in Japan.
J Infect Chemother. 2021.
Okuhama A, Hotta M, Ishikane M, Kawashima A, Miyazato Y, Terada M, Yamada G, Kanda K, Inada M, Sato L, Sato M,
Akiyama Y, Suzuki T, Nakamoto T, Nomoto H, Ide S, Nakamura K, Saito S, Kinoshita N, Yamamoto K, Morioka S, Ujiie M,

162

2021/10/19

Hayakawa K, Kustuna S, Shida Y, Tajima T, Teruya K, Funato Y, Yamamoto M, Izumi S, Hojo M, Sugiyama H, Ohmagari N.
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus disease.
J Infect Chemother. 2021.
Nomoto H, Suzuki S, Asai Y, Hayakawa K, Gatanaga H, Terada M, Suzuki K, Ohtsu H, Toyoda A, Ohmagari N.

163

2021/10/28

Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan.
J Infect Chemother. 2021.
Wakabayashi M, Ezoe S, Yoneda M, Katsuma Y, Iso H.

1642021/10/21

Global landscape of the COVID-19 vaccination policy: Ensuring equitable access to quality-assured vaccines.
GHM Open. 2021.
Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Kawaoka Y.

165

2021/10/29

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2.
Viruses. 2021;13(11):2183.
Sakamaki K, Uemura Y, Shimizu Y.

166

2021/11/8

Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional
analysis of trials registered in ClinicalTrials.gov.
Trials. 2021.
Ide S, Saito S, Akazawa T, Furuya T, Masuda J, Nagashima M, Asai Y, Ogawa T, Yamamoto R, Ishioka H, Kanda K,
Okuhama A, Wakimoto Y, Suzuki T, Akiyama Y, Miyazato Y, Nakamura K, Nakamoto T, Nomoto H, Moriyama Y, Ota M,

167

2021/11/16

Morioka S, Matsuda W, Uemura T, Kobayashi K, Sasaki R, Katagiri D, Kutsuna S, Hayakawa K, Ohmagari N.
Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe
coronavirus disease 2019.
IDCases. 2021.
Uraki R, Kawaoka Y.

168

2021/11/9

Host glycolipids in SARS-CoV-2 entry.
Nat Chem Biol. 2021
Mizoue T, Yamamoto S, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Ohmagari N.

1692021/11/25

Sensitivity of three antibody assays to SARS-CoV-2 nucleocapsid protein in relation to timing since diagnosis.
GHM Open. 2021.
Saito A, Irie T, Suzuki R, Maemura T, Nasser H, Uriu K, Kosugi Y, Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, IwatsukiHorimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka YL, Shimizu R, Shimizu K,
Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R,

170

2021/11/25

Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M; Genotype to Phenotype Japan (G2P-Japan) Consortium, Tanaka S,
Nakagawa S, Ikeda T, Fukuhara T, Kawaoka Y, Sato K.
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
Nature. 2021
Morita C, Suzuki M, Izumi S, Tsukada A, Tsujimoto Y, Sakamoto K, Hashimoto M, Takasaki J, Ohmagari N, Hojo M.

1712021/11/26

Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during
the first wave of infections.
Respir Investig. 2021.
Asai Y, Nomoto H, Hayakawa K, Matsunaga N, Tsuzuki S, Terada M, Ohtsu H, Kitajima K, Suzuki K, Suzuki T, Nakamura K,
Morioka S, Saito S, Saito F, Ohmagari N.

172

2022/1/7

Comorbidities as Risk Factors for Severe Disease in Hospitalized Elderly COVID-19 Patients by Different Age-Groups inJapan.
Gerontology. 2022.
Terakawa K, Katagiri D, Shimada K, Sato L, Takano H.

1742021/11/27

Safety of casirivimab/imdevimab administration in a SARS-CoV-2 positive maintenance dialysis patient in Japan.
CEN Case Rep. 2022.
Matsushita Y, Yokoyama T, Hayakawa K, Matsunaga N, Ohtsu H, Saito S, Terada M, Suzuki S, Morioka S, Kutsuna S,

173

2021/12/11

Mizoue T, Hara H, Kimura A, Ohmagari N.
Smoking and severe illness in hospitalized COVID-19 patients in Japan.
Int J Epidemiol. 2021.
Neumann G、Kawaoka Y.

175

2021/11/24

Quo Vadis Influenza?
China CDC Wkly. 2021;3(49): 1046-1048.

8

2024/08/19 更新
通し番号オンラインリリース日

論文Citation
Uraki R, Imai M, Ito M, Shime H, Odanaka M, Okuda M, Kawaoka Y, Yamazaki S.

176

2021/12/9

Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2
antigens.

DOI情報

邦文要旨掲載有無

https://doi.org/10.1371/journal.ppat.1010085あり

https://doi.org/10.35772/ghm.2021.01124

あり

https://doi.org/10.1093/cid/ciab1048あり

https://doi.org/10.1093/cid/ciab1072あり

https://doi.org/10.1136/bmjnph-2021-000364

なし

https://doi.org/10.1016/ S0140-6736(22)00101-5なし

https://doi.org/10.1002/npr2.12230

あり

https://doi.org/10.35772/ghm.2021.01114

なし

https://doi.org/10.1038/s41586-022-04441-6

掲載予定

https://doi.org/10.1016/j.nutos.2022.01.002あり

https://doi.org/10.2188/jea.JE20210458

なし

https://doi.org/10.1253/circj.CJ-21-0687

あり

https://doi.org/10.1056/NEJMc2119407

掲載予定

https://doi.org/10.1186/s41182-022-00404-9あり

https://doi.org/10.1016/j.jiph.2022.01.014あり

https://doi.org/10.1001/jama.2022.0818

あり

https://doi.org/10.1016/j.jiac.2022.02.004あり

https://doi.org/10.3201/eid2804.212585

あり

https://doi.org/10.35772/ghmo.2021.01032

あり

PLoS Pathog. 2021.
Okumura N, Tsuzuki S, Saito S, Saito T, Takasago S, Hojo M, Iwamoto N, Ohmagari Norio.
1772021/12/29

The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: a focus on viral dynamics.
Glob Health Med. 2021.
Yamamoto S, Maeda K, Matsuda K, Tanaka A, Horii K, Okudera K, Takeuchi JS, Mizoue T, Konishi M, Ozeki M, Sugiyama H,
Aoyanagi N, Mitsuya H, Sugiura W, Ohmagari N.

178

2021/12/24

COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral
hospital in Tokyo: a case-control matching study.
Clin Infect Dis. 2021.
Maruki T, Iwamoto N, Kanda K, Okumura N, Yamada G, Ishikane M, Ujiie M, Saito M, Fujimoto T, Kageyama T, Saito T,
Saito S, Suzuki T, Ohmagari N.

179

2022/1/3

Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international
travelers to Japan.
Clin Infect Dis. 2022.
Funaki T, Sanpei M, Morisaki N, Mizoue T and Yamaguchi K.

1802022/1/4

Serious vitamin D deficiency in healthcare workers during the COVID-19 pandemic.
BMJ Nutr Prev Health. 2022.
ITAC (INSIGHT 013) Study Group.

181

2022/1/27

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3,
randomised trial.
Lancet. 2022.
Miki T, Yamamoto S, Fukunaga A, Inoue Y, Ishiwari H, Ishii M, Miyo K, Konishi M, Ohmagari N, Mizoue T.

182

2022/2/2

Association between eating balanced meals and depressive symptoms in Japanese hospital workers during the COVID-19
pandemic.
Neuropsychopharmacol Rep. 2022;42(1):109-113.
Soh M, Hifumi T, Otani N, Maki K, Hayashi M, Miyazaki M, Kobayashi K, Ageishi R, Hatakeyama J, Kurihara T, Ishimatsu S.

1832022/1/17

Trends in endotracheal intubation for patients with COVID-19 by emergency physicians.
Glob Health Med. 2021.
Halfmann PJ, Iida S, Iwatsuki-Horimoto K, Maemura T, Kiso M, Scheaffer SM, Darling TL, Joshi A, Loeber S, Singh G,
Foster SL, Ying B, Case JB, Chong Z, Whitener B, Moliva J, Floyd K, Ujie M, Nakajima N, Ito M, Wright R, Uraki R, Warang
P, Gagne M, Li R, Sakai-Tagawa Y, Liu Y, Larson D, Osorio JE, Hernandez-Ortiz JP, Henry AR, Ciouderis K, Florek KR, Patel
M, Odle A, Wong LR, Bateman AC, Wang Z, Edara VV, Chong Z, Franks J, Jeevan T, Fabrizio T, DeBeauchamp J, Kercher L,

184

2022/1/21

Seiler P, Gonzalez-Reiche AS, Sordillo EM, Chang LA, van Bakel H, Simon V; Consortium Mount Sinai Pathogen
Surveillance (PSP) study group, Douek DC, Sullivan NJ, Thackray LB, Ueki H, Yamayoshi S, Imai M, Perlman S, Webby RJ,
Seder RA, Suthar MS, García-Sastre A, Schotsaert M, Suzuki T, Boon ACM, Diamond MS, Kawaoka Y. SARS-CoV-2
Omicron virus causes attenuated disease in mice and hamsters.
Nature. 2022
Nanri A, Yamamoto S, Konishi M, Ohmagari N, Mizoue T.

1852022/1/13

Green tea consumption and SARS-CoV-2 infection among staff of a referral hospital in Japan.
Clin Nutr Open Sci. 2022.
Hosokawa Y, Okawa S, Hori A, Morisaki N, Takahashi Y, Fujiwara T, Nakayama SF, Hamada H, Satoh T, Tabuchi T.

186

2022/1/29

The prevalence of COVID-19 vaccination and vaccine hesitancy in pregnant women: an internet-based cross-sectional
study in Japan.
J Epidemiol. 2022
Hiroi Y, Ohtsu H, Uemura Y, Hayakawa K, Asai Y, Kutsuna S, Terada M, Sugiura W, Ohmagari N.

187

2022/1/29

Cardiovascular Complications of Hospitalized Patients With Coronavirus Disease 2019 in a Japanese Registry in 2020.
Circ J. 2022.
Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Chiba S, Halfmann P,
Nagai H, Saito M, Adachi E, Sullivan D, Pekosz A, Watanabe S, Maeda K, Imai M, Yotsuyanagi H, Mitsuya H, Ohmagari N,

1882022/1/26

Takeda M, Hasegawa H, Kawaoka Y.
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.
N Engl J Med. 2022.
Kiyohara H, Teshima Y, Hoshino HA, Kanda M, Matsuoka S, Iwamoto A, Fujita M.

189

2022/2/1

Three myths of disseminating COVID-19 information to vulnerable migrants in Japan: lessons learned during the pandemic.
Trop Med Health. 2022;50(1):13.
Akiyama Y, Morioka S, Asai Y, Sato L, Suzuki S, Saito S, Matsunaga N, Hayakawa K, Ohmagari N.

190

2022/1/31

Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using thenationwide Japanese registry, COVIREGI-JP.
J Infect Public Health. 2022;75(1):36-40.
Akashi H, Shimada S, Tamura T, Chinda E, Kokudo N.

191

2022/2/3

SARS-CoV-2 Infections in Close Contacts of Positive Cases in the Olympic and Paralympic Village at the 2021 Tokyo
Olympic and Paralympic Games.
JAMA. 2022;327(10):978-980.
Ishikane M, Unoki-Kubota H, Moriya A, Kutsuna S, Ando H, Kaburagi Y, Suzuki T, Iwamoto N, Kimura M, Ohmagari N.

192

2022/2/9

Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 panel, a rapid multiplex PCR method for the diagnosis of COVID-19.
J Infect Chemother. 2022.
Miyazato Y, Yamamoto K, Yamada G, Kubota S, Ishikane M, Sugiyama M, Ueno M, Matsunaga A, Miyoshi-Akiyama T,

193

2022/2/11

Ishizaka Y, Ohmagari N.
Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.
Emerg Infect Dis. 2022;28(4):870-872.
Wakabayashi M, Ichimura Y, Shimizu E, Nishioka T, Kono Y, Doi M, Egami Y, Kadowaki T, Iso H, Fujita N.

1942022/2/26

Global extension of Japanese medical products related to COVID-19: a survey of WHO Emergency Use Listing.
GHM open. 2022.
Uchihara M, Bouchi R, Kodani N, Saito S, Miyazato Y, Umamoto K, Sugimoto H, Kobayashi M, Hikida S, Akiyama Y, Ihana-

1952022/1/24

Sugiyama N, Ohsugi M, Tanabe A, Ueki K, Takasaki J, Hojo M, Kajio H.

https://onlinelibrary.wiley.com/doi/full/10.1111/j

Impact of newly diagnosed diabetes on coronavirus disease 2019 severity and hyperglycemia.

di.13754

あり

J Diabetes Investig. 2022.
Tsuzuki S, Hayakawa K, Uemura Y, Shinozaki T, Matsunaga N, Terada M, Suzuki S, Asai Y, Kitajima K, Saito S, Yamada G,
Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N.
196

2022/2/19

Efficacy of remdesivir in hospitalized nonsevere COVID-19 patients in Japan: A large observational study using the COVID-

https://doi.org/10.1016/j.ijid.2022.02.039

あり

19 Registry Japan.
Int J Infect Dis. 2022;118:119-125.
Okawa S, Hosokawa Y, Nanishi K, Zaitsu M, Tabuchi T.
197

2022/2/25

Threatened abortion, threatened premature labor, and preterm birth during the first state of emergency for COVID-19 in2020 in Japan.

https://obgyn.onlinelibrary.wiley.com/doi/10.111
1/jog.15203

J Obstet Gynaecol Res. 2022

9あり

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1002/oby.23417

あり

https://doi.org/10.7883/yoken.JJID.2021.232あり

https://doi.org/10.35772/ghm.2021.01121

あり

Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Miyo K, Sugiura W, Sugiyama H, Ohmagari N.
198

2022/2/28

Sex-associated differences between body mass index and SARS-CoV-2 antibody titers following the BNT162b2 vaccine.
Obesity (Silver Spring). 2022
Suzuki M, Hayakawa K, Asai Y, Matsunaga N, Terada M, Ohtsu H, Toyoda A, Takasaki J, Hojo M, Yanagawa Y, Saito S,

199

2022/2/28

Yamamoto K, Ide S, Akiyama Y, Suzuki T, Moriya A, Mezaki K, Ohmagari N.
Evaluation of the detection of other pathogens in hospitalized patients with COVID-19 at a tertiary hospital in Japan.
Jpn J Infect Dis. 2022
Sekihara K, Shibasaki T, Okamoto T, Matsumoto C, Ito K, Fujimoto K, Kato F, Matsuda W, Kobayashi K, Sasaki R,
Uemura T, Kimura A, Sugiyama H, Kokudo N.

200

2022/3/5

Poor prognosis of patients with severe COVID-19 admitted to an infectious disease intensive care unit during the pandemic
caused by the Delta variant in Japan.
Glob Health Med. 2022.
Katagiri D, Izumi S, Takano H.

201

2022/3/5

When should polymyxin B-immobilized polystyrene column be introduced to improve COVID-19 prognosis?
Ther Apher Dial. 2022.

https://onlinelibrary.wiley.com/doi/10.1111/1744-9987.13825

あり

Beppu H, Ogawa T, Ishikane M, Kawanishi T, Fukuda T, Sato L, Matsunaga A, Maeda K, Katagiri D, Ishizaka Y, Mitsuya H,
203

2022/3/9

Ohmagari N, Yasui F, Kohara M, Kikuchi K, Wakai S.
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.

https://doi.org/10.1007/s13730-022-00697-z

なしhttps://doi.org/10.1016/j.idcr.2022.e01475

あり

https://doi.org/10.1038/s41598-022-07856-3あり

https://doi.org/10.1128/spectrum.01689-21

なし

https://www.doi.org/10.1056/NEJMc2201933

掲載予定

https://doi.org/10.3390/v14030562

掲載予定

https://doi.org/10.1007/s40121-022-00617-9あり

https://doi.org/10.1016/j.lanwpc.2022.100421

あり

https://doi.org/10.35772/ghmo.2022.01002

なし

CEN Case Rep. 2022.
Ide S, Kurozumi A, Takeshige A, Shimomura A, Watanabe R, Inagaki T.
202

2022/3/5

Fasciitis of the lower leg after COVID-19 vaccination.
IDCases. 2022;28:e01475.
Nishida N, Sugiyama M, Kawai Y, Naka I, Iwamoto N, Suzuki T, Suzuki M, Miyazato Y, Suzuki S, Izumi S, Hojo M, Tsuchiura

206

2022/3/9

T, Ishikawa M, Ohashi J, Ohmagari N, Tokunaga K, Mizokami M.
Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19.
Sci Rep. 2022;12(1):3854.
Mizutani T, Ishizaka A, Koga M, Ikeuchi K, Saito M, Adachi E, Yamayoshi S, Iwatsuki-Horimoto K, Yasuhara A, Kiyono H,
Matano T, Suzuki Y, Tsutsumi T, Kawaoka Y, Yotsuyanagi H.

204

2022/3/7

Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Diseaseduring Hospitalization.
Microbiol Spectr. 2022
Takashita E, Kinoshita N, Yamayoshi S, Sakai-Tagawa Y, Fujisaki S, Ito M, Iwatsuki-Horimoto K, Halfmann P, Watanabe S,

205

2022/3/9

Maeda K, Imai M, Mitsuya H, Ohmagari N, Takeda M, Hasegawa H, Kawaoka Y.
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2.
N Engl J Med. 2022;386(15):1475-1477.
Pattinson D, Jester P, Guan L, Yamayoshi S, Chiba S, Presler R, Rao H, Iwatsuki-Horimoto K, Ikeda N, Hagihara M, Uchida2072022/3/9

T, Mitamura K, Halfmann P, Neumann G, Kawaoka Y.
A Novel Method to Reduce ELISA Serial Dilution Assay Workload Applied to SARS-CoV-2 and Seasonal HCoVs.
Viruses. 2022;14(3):562.
Tsuzuki S, Hayakawa K, Doi Y, Shinozaki T, Uemura Y, Matsunaga N, Terada M, Suzuki S, Asai Y, Yamada G, Saito S,
Shibata T, Kondo M, Izumi K, Hojo M, Mizoue T, Yokota K, Nakamura-Uchiyama F, Saito F, Sugiura W, Ohmagari N.

209

2022/3/21

Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID19 Registry Japan.
Infect Dis Ther. 2022.
Matsunaga N, Hayakawa K, Asai Y, Tsuzuki S, Terada M, Suzuki S, Ohtsu H, Kitajima K, Toyoda A, Suzuki K, Suzuki M,
Saito S, Uemura Y, Shibata T, Kondo M, Nakamura-Uchiyama F, Yokota K, Saito F, Izumi K, Sugiura W, Ohmagari N.

208

2022/3/16

Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread useof vaccination: a nationwide observational study.
Lancet Reg Health West Pac. 2022;22:100421.
Kutsuna S, Saito S, Takamatsu Y, Terada M, Togano T, Kinoshita N, Maeda K, Matsunaga A, Satake M, Matsubayashi K,
Tsuno N・H, Kojima M, Kuramitsu M, Tezuka K, Ikebe E, Okuma K, Hamaguchi I, Shimanishi Y, Hangaishi A, Ishizaka Y,

210

2022/3/21

Ohmagari N, Mitsuya H.
Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label,
single-arm, interventional study in Japan.
GHM Open. 2022.
Takahashi K, Ishikane M, Ujiie M, Iwamoto N, Okumura N, Sato T, Nagashima M, Moriya A, Suzuki M, Hojo M, Kanno T,

211

2022/3/15

Saito S, Miyamoto S, Ainai A, Tobiume M, Arashiro T, Fujimoto T, Saito T, Yamato M, Suzuki T, Ohmagari N.
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.

https://wwwnc.cdc.gov/eid/article/28/5/220197_article

ありEmerg Infect Dis. 2022;28(5):998-1001.
Yamamoto S, Fukunaga A, Tanaka A, Takeuchi JS, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W,
Ohmagari N.
212

2022/3/18

Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19

https://doi.org/10.1016/j.vaccine.2022.02.052あり

https://doi.org/10.1002/rcr2.938あり

https://doi.org/10.1016/j.ijid.2022.03.017

あり

https://doi.org/10.1016/j.antiviral.2022.105297

あり

vaccine.
Vaccine. 2022;40(13):1924-1927.
So C, Izumi S, Ishida A, Hirakawa R, Kusaba Y, Hashimoto M, Ishii S, Miyazaki H, Iikura M, Hojo M.
2142022/3/23

COVID-19 mRNA vaccine-related interstitial lung disease: Two case reports and literature review.
Respirol Case Rep. 2022;10(4):e0938.
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Iwamoto N, Ujiie M, Kutsuna S, Morioka S, Ishizaka Y, Mitsuya H,
Ohmagari N.

213

2022/3/16

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 reinfection.
Int J Infect Dis. 2022.
Ueno M, Iwata-Yoshikawa N, Matsunaga A, Okamura T, Saito S, Ashida S, Yoshida I, Nagashima M, Asakura H, Yaoita Y,
Suzuki J, Sadamasu K, Yoshimura K, Kutsuna S, Shiwa-Sudo N, Nagata N, Suzuki T, Suzuki A, Okamoto M, Kimura M,

215

2022/3/24

Ohmagari N, Miura R, Ishizaka Y.
Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including
the Omicron variants.
Antiviral Res. 2022;201:105297.
Fujii T, Hagihara M, Mitamura K, Nakashima S, Ohara S, Uchida T, Inoue M, Okuda M, Yasuhara A, Murakami J, Duong C,

216

2022/3/26

Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y.

https://doi.org/10.2169/internalmedicine.9209-

Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan.

21

掲載予定

Intern Med. 2022.
Miyazato Y, Yamamoto K, Nakaya Y, Morioka S, Takeuchi JS, Takamatsu Y, Maeda K, Kimura M, Sugiura W, Mitsuya H,
Yano M, Ohmagari N.
217

2022/3/20

Successful use of casirivimab/imdevimab anti-spike monoclonal antibodies to enhance neutralizing antibodies in a woman

https://doi.org/10.1016/j.jiac.2022.03.002あり

https://doi.org/10.1128/msphere.00941-21

掲載予定

on anti-CD20 treatment with refractory COVID-19.
J Infect Chemother. 2022.
Ueki H, Ito M, Furusawaa Y, Yamayosh iS, Inoue S, Kawaoka Y.
218

2022/3/17

A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols.
mSphere. 2022.

10

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1371/journal.pone.0266260

あり

https://doi.org/10.1016/j.lanwpc.2022.100442

あり

https://doi.org/10.35772/ghm.2022.01013

あり

https://doi.org/10.35772/ghm.2022.01016

あり

https://doi.org/10.35772/ghm.2022.01006

あり

https://doi.org/10.35772/ghm.2022.01001

あり

https://doi.org/10.35772/ghm.2022.01024

あり

https://doi.org/10.35772/ghm.2022.01023

あり

https://doi.org/10.35772/ghm.2022.01004

あり

https://doi.org/10.35772/ghm.2022.01022

あり

https://doi.org/10.35772/ghm.2022.01015

あり

https://doi.org/10.1016/j.jjcc.2022.04.001

なし

https://doi.org/10.35772/ghm.2022.01017

あり

https://doi.org/10.1016/j.celrep.2022.110799

なし

https://doi.org/10.1016/j.jiac.2022.04.018

あり

http://dx.doi.org/10.1136/sextrans-2021-055378

なし

https://doi.org/10.35772/ghm.2022.01027

あり

https://doi.org/10.1016/j.ijid.2022.04.058

あり

https://doi.org/10.1002/ajhb.23750

あり

https://doi.org/10.1016/j.jiac.2022.04.025あり

https://doi.org/10.14932/jamt.21-86あり

https://doi.org/10.11477/mf.1401209716

あり

https://doi.org/10.35772/ghm.2022.01008

あり

https://doi.org/10.35772/ghm.2022.01036

なし

https://doi.org/10.1007/s41649-022-00207-4

なし

Fukunaga A, Inoue Y, Yamamoto S, Miki T, Hoang DV, Manandhar Shrestha R, Ishiwari H, Ishii M, Miyo K, Konishi M,
Ohmagari N, Mizoue T.
219

2022/4/7

Association between chronic physical conditions and depressive symptoms among hospital workers in a national medical
institution designated for COVID-19 in Japan.
PLoS One. 2022;17(4):e0266260.
Yamaguchi T, Iwagami M, Ishiguro C, Fujii D, Yamamoto N, Narisawa M, Tsuboi T, Umeda H, Kinoshita N, Iguchi T, Noda T,

220

2022/3/29

Tsuruta S, Oka A, Morio T, Nakai K, Hayashi S.
Safety monitoring of COVID-19 vaccines in Japan.
Lancet Reg Health West Pac. 2022;23:100442.
Matsunaga A, Tsuzuki S, Morioka S, Ohmagari N, Ishizaka Y.

221

2022/4/6

Long COVID: current status in Japan and knowledge about its molecular background.
Glob Health Med. 2022.
Minamimoto R, Hotta M, Okafuji T, Tsutui S, Tsukuda M, Nakayama H, Shida Y, Tajima T.

222

2022/3/31

Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT.
Glob Health Med. 2022.
Tomidokoro D, Hiroi Y.

223

2022/3/31

Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan.
Glob Health Med. 2022.
Sasaki Y, Sasaki S, Sunakawa H, Toguchi Y, Tanese S, Saito K, Shinohara R, Kurokouchi T, Sugimoto K, Itagaki K, Yoshida
Y, Namekata S, Takahashi M, Harada I, Hakosima Y, Inazaki K, Yoshimura Y, Mizumoto Y, Okada T, Usam M.

225

2022/3/31

Evaluating the daily life of child and adolescent psychiatric outpatients during temporary school closure over COVID-19
pandemic: A single-center case-control study in Japan.
Glob Health Med. 2022.
Seto K, Ohashi Y, Masuda J, Terakado H.

2262022/4/9

Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishmentof an adverse drug reaction reporting system.
Glob Health Med. 2022.
Ujiie M.

227

2022/4/9

Establishment of an emergency regulatory approval system in Japan in response to the COVID-19 pandemic andchallenges in developing domestically produced vaccines.
Glob Health Med. 2022.
Katagiri D.

224

2022/3/31

For safe and adequate blood purification therapy in severe COVID-19 - what we have learned so far.
Glob Health Med. 2022.
Akashi H, Kodoi H, Noda S, Tamura T, Baba H, Chinda E, Thandar MM, Naito K, Watanabe Y, Suzuki Y, Narita T, Shimazu

228

2022/4/9

229

2022/4/9

T.
Reporting on the implementation to set up a "care and isolation facility" for mild COVID-19 cases in Tokyo.
Glob Health Med. 2022.
Nomoto H, Hayakawa K, Ohmagari N.
Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan.
Glob Health Med. 2022.
Yoshihara F, Ohtsu H, Nakai M, Tsuzuki S, Hayakawa K, Terada M, Matsunaga N, Yasuda S, Ogawa H, Ohmagari N.

230

2022/4/8

Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure,
Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan.
J Cardiol. 2022:S0914-5087(22)00082-X.
Ohmagari N.

231

2022/4/30

How did the Tokyo Metropolitan Government respond to COVID-19?
Glob Health Med. 2022; 4(2):67-70.
Chong Z, Karl CE, Halfmann PJ, Kawaoka Y, Winkler ES, Keeler SP, Holtzman MJ, Yu J, Diamond MS. Nasally delivered

233

2022/4/21

interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron.
Cell Rep. 2022; 39(6):110799.
Okumura N, Tsuzuki S, Saito S, Hattori S, Takeuchi S. J, Saito T, Ujiie M, Hojo M, Iwamoto N, Sugiura W, Mitsuya H,
Ohmagari N.

234

2022/4/22

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant inJapan.
Journal of Infection and Chemotherapy. 2022.
Ghaznavi C, Tanoue Y, Kawashima T, Eguchi A, Yoneoka D, Sakamoto H, Ueda P, Ishikane M, Ando N, Miyazato Y, Nomura

235

2022/4/22

232

2022/4/13

S.
Recent changes in the reporting of STIs in Japan during the COVID-19 pandemic.
Sex Transm Infect. 2022:sextrans-2021-055378.
Kamegai K, Sakai T, Teruya S, Kuba K, Ohmagari N.
Perspectives on countermeasures against COVID-19 in the remote islands of Yaeyama region, Okinawa, Japan.
Glob Health Med. 2022.
Kamegai K, Iwamoto N, Togano T, Maeda K, Takamatsu Y, Miyazato Y, Ishikane M, Mizokami M, Sugiyama M, Iida S,

236

2022/4/30

Miyamoto S, Suzuki T, Ohmagari N.
A Fatal Breakthrough Coronavirus Disease 2019 Case Following Bendamustine-Rituximab Therapy.
Int J Infect Dis. 2022:S1201-9712(22)00258-2.
Inoue Y, Mizoue T.

237

2022/4/6

238

2022/5/17

A preliminary analysis of the secondary sex ratio decline after the COVID-19 pandemic in Japan.
Am J Hum Biol. 2022:eajhb.
Miyazato Y, Tsuzuki S, Morioka S, Terada M, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada M, Akashi M, Kuge C,
Osanai Y, Tanaka K, Suzuki M, Hayakawa K, Ohmagari N.
Factors associated with development and persistence of post-COVID conditions: A cross-sectional study.
J Infect Chemother. 2022:S1341-321X(22)00139-8.
屋良朝仁, 葉山裕真, 廣井透雄, 川口港, 小関満.

239

2022/4/25

COVID-19中等症患者における急性期と回復期の心機能に関する4症例の比較.
医学検査. 2022; 71(2):362-368
若林真美, 江副聡, 米田麻希子, 磯博康.

2402021/10/15

新型コロナワクチンを公平に分配するための世界的取り組み.
公衆衛生. 2021; 85(10):697-701.
Terada-Hirashima J, Sugiura W, Shimizu Y, Tanaka Y, Uemura Y, Ishikane M, Kazuyama Y, Ikeda M, Wakabayashi K,
Ohmagari N, Kimura M.

2412022/5/14

Investigation of the use of PCR testing prior to ship boarding to prevent the spread of SARS-CoV-2 from urban areas toless populated remote islands.
Glob Health Med. 2022.
Song P, Mitsuya H, Kokudo N.

243

2022/4/30

COVID-19 in Japan: An update on national policy, research, clinical practice, and vaccination campaign.
Glob Health Med. 2022; 4(2):64-66.
Nakada H, Takashima K, Maru Y, Ikka T, Yuji K, Yoshida S, Matsui K.

242

2022/5/11

Public Attitudes toward COVID-19 Vaccinations before Dawn in Japan: Ethics and Future Perspectives.
Asian Bioeth Rev. 2022.

11

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/S2213-2600(22)00088-1

なし

https://doi.org/10.3390/vaccines10050776

あり

https://doi.org/10.1111/eci.13808

あり

https://doi.org/10.1038/s41586-022-04856-1あり

Wolfe CR, Tomashek KM, Patterson TF, Gomez CA, Marconi VC, Jain MK, Yang OO, Paules CI, Palacios GMR, Grossberg R,
Harkins MS, Mularski RA, Erdmann N, Sandkovsky U, Almasri E, Pineda JR, Dretler AW, de Castilla DL, Branche AR, Park
PK, Mehta AK, Short WR, McLellan SLF, Kline S, Iovine NM, El Sahly HM, Doernberg SB, Oh MD, Huprikar N, Hohmann E,
Kelley CF, Holodniy M, Kim ES, Sweeney DA, Finberg RW, Grimes KA, Maves RC, Ko ER, Engemann JJ, Taylor BS, Ponce
244

2022/5/23

PO, Larson L, Melendez DP, Seibert AM, Rouphael NG, Strebe J, Clark JL, Julian KG, de Leon AP, Cardoso A, de Bono S,
Atmar RL, Ganesan A, Ferreira JL, Green M, Makowski M, Bonnett T, Beresnev T, Ghazaryan V, Dempsey W, Nayak SU,
Dodd LE, Beigel JH, Kalil AC ACTT-4 Study Group.
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double
placebo-controlled trial.
Lancet Respir Med. 2022:S2213-2600(22)00088-1.
Islam Z, Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Sugiura W, Ohmagari N.

245

2022/5/13

Association of Impaired Fasting Glucose and Diabetes with SARS-CoV-2 Spike Antibody Titers after the BNT162b2
Vaccine among Health Care Workers in a Tertiary Hospital in Japan.
Vaccines (Basel). 2022; 10(5):776.
Suzuki T, Iwamoto N, Tsuzuki S, Kakumoto Y, Suzuki M, Ashida S, Oshiro Y, Nemoto T, Kanda K, Okuhama A, Yamada G,
Inada M, Sato L, Miyazato Y, Akiyama Y, Saito S, Morioka S, Ujiie M, Hayakawa K, Sugiyama M, Mizokami M, Kodama EN,

246

2022/5/4

Ohmagari N.
Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement.
Eur J Clin Invest. 2022:e13808.
Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann PJ, Loeber S, Maemura T, Yamayoshi S, Fujisaki S, Wang
Z, Ito M, Ujie M, Iwatsuki-Horimoto K, Furusawa Y, Wright R, Chong Z, Ozono S, Yasuhara A, Ueki H, Sakai-Tagawa Y, Li R,
Liu Y, Larson D, Koga M, Tsutsumi T, Adachi E, Saito M, Yamamoto S, Hagihara M, Mitamura K, Sato T, Hojo M, Hattori SI,

247

2022/5/16

Maeda K, Valdez R; IASO study team, Okuda M, Murakami J, Duong C, Godbole S, Douek DC, Maeda K, Watanabe S,
Gordon A, Ohmagari N, Yotsuyanagi H, Diamond MS, Hasegawa H, Mitsuya H, Suzuki T, Kawaoka Y.
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2.
Nature. 2022.
Halfmann PJ, Kuroda M, Armbrust T, Theiler J, Balaram A, Moreno GK, Accola MA, Iwatsuki-Horimoto K, Valdez R,
Stoneman E, Braun K, Yamayoshi S, Somsen E, Baczenas JJ, Mitamura K, Hagihara M, Adachi E, Koga M, McLaughlin M,

248

2022/5/17

Rehrauer W, Imai M, Yamamoto S, Tsutsumi T, Saito M, Friedrich TC, O'Connor SL, O'Connor DH, Gordon A, Korber B,
Kawaoka Y.

https://www.science.org/doi/10.1126/scitranslm
ed.abm4908

掲載予定

Characterization of the SARS-CoV-2 B.1.621 (Mu) variant.
Sci Transl Med. 2022:eabm4908.
Nanishi K, Okawa S, Hongo H, Shibanuma A, Abe SK, Tabuchi T.
249

2022/5/19

Influence of the COVID-19 pandemic on breastfeeding support for healthy mothers and the association between
compliance with WHO recommendations for breastfeeding support and exclusive breastfeeding in Japan.

https://doi.org/10.7717/peerj.13347

なし

https://doi.org/10.35772/ghm.2022.01033

あり

PeerJ. 2022; 10:e13347.
Hayakawa K, Asai Y, Matsunaga N, Tsuzuki S, Terada M, Suzuki S, Kitajima K, Saito S, Ohmagari N.
250

2022/5/29

Evaluation of the representativeness of data in the COVID-19 Registry Japan during the first six waves of the epidemic.
Glob Health Med. 2022.
若林真美, 磯博康.

2512022/5/25

あり

COVAXファシリティによって世界のワクチン格差は是正できるか？
日本社会精神医学会雑誌. 2022; 31:134-145.
大曲貴夫.

252

2022/4/28

臨床情報の収集・分析と課題.

https://doi.org/10.4091/iken.32-51あり

https://doi.org/10.35772/ghm.2022.01005

あり

医療と社会. 2022; 32(1):5158.
Sato T.
254

2022/6/6

Responding to COVID-19: Establishing a nursing system that is appropriate for the new post-epidemic era.
Glob Health Med. 2022.
Ghaznavi C, Sakamoto H, Kawashima T, Horiuchi S, Ishikane M, Abe SK, Yoneoka D, Eguchi A, Tanoue Y, Hashizume M,

253

2022/5/31

Nomura S.

https://doi.org/10.1007/s12519-022-00575-9

Decreased incidence followed by comeback of pediatric infections during the COVID-19 pandemic in Japan.

なし

World J Pediatr. 2022:1–4.
Shigemi D, Tabuchi T, Okawa S, Yasunaga H.
255

2022/6/1

Association between health literacy and COVID-19 prevention behaviors among pregnant and postpartum women.

https://doi.org/10.1080/14767058.2022.2081498

なし

https://doi.org/10.7326/m22-0729

なし

https://doi.org/10.1016/j.ijid.2022.04.035

なし

https://doi.org/10.11406/rinketsu.63.403

なし

https://doi.org/10.3390/life12060856

あり

https://doi.org/10.1016/j.jiac.2022.06.001

あり

https://doi.org/10.1038/s41564-022-01170-4

掲載予定

http://dx.doi.org/10.1136/bmjopen-2022-060829

あり

https://doi.org/10.1136/gpsych-2022-100802

なし

J Matern Fetal Neonatal Med. 2022:1-7.
服部浩, 島津浩, 高橋聡, ハイジッヒ ベアテ.
2562022/6/4

サイトカインストーム関連疾患に対する新規分子標的―血液線維素溶解系因子群―.
臨床血液. 2022; 63(5):403～409.
Hung DT, Ghula S, Aziz JMA, Makram AM, Tawfik GM, Abozaid AA, Pancharatnam RA, Ibrahim AM, Shabouk MB, Turnage
M, Nakhare S, Karmally Z, Kouz B, Le TN, Alhijazeen S, Phuong NQ, Ads AM, Abdelaal AH, Nam NH, Iiyama T, Kita K,

257

2022/4/22

Hirayama K, Huy NT.
The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of
published clinical trials and observational studies.
Int J Infect Dis. 2022; 120:217-227.
Johnson MG, Puenpatom A, Moncada PA, Burgess L, Duke ER, Ohmagari N, Wolf T, Bassetti M, Bhagani S, Ghosn J, Zhang
Y, Wan H, Williams-Diaz A, Brown ML, Paschke A, De Anda C.

258

2022/6/7

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized,
Placebo-Controlled Trial.
Ann Intern Med. 2022.
Tomita N, Saito S, Terada-Hirashima J, Mikami A, Uemura Y, Kutsuna S, Nomoto H, Fujisawa K, Nagashima M, Terada M,
Ashida S, Morioka S, Satake M, Hangaishi A, Togano T, Shiratori K, Takamatsu Y, Maeda K, Ohmagari N, Sugiura W,

259

2022/6/8

Mitsuya H.
A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy forCoronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT).
Life. 2022; 12(6):856.
Hayakawa K, Morioka S, Asai Y, Tsuzuki S, Yamada G, Suzuki S, Matsunaga N, Ohmagari N.

260

2022/6/13

Predictors of silent hypoxia in hospitalized patients with COVID-19 in Japan.
J Infect Chemother. 2022:S1341-321X(22)00176-3.
Uraki R, Kiso M, Imai M, Yamayoshi S, Ito M, Fujisaki S, Takashita E, Ujie M, Furusawa Y, Yasuhara A, Iwatsuki-Horimoto

261

2022/6/15

K, Sakai-Tagawa Y, Watanabe S, Hasegawa H, Kawaoka Y.
Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters.
Nat Microbiol. 2022.
Okamoto S, Kamimura K, Komamura K.

262

2022/6/16

COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan.
BMJ Open. 2022; 12(6):e060829.
Murata F, Maeda M, Ishiguro C, Fukuda H.

263

2022/6/21

Acute and delayed psychiatric sequelae among patients hospitalised with COVID-19: a cohort study using LIFE study data.
General Psychiatry 2022; 35:e100802.

122024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.35772/ghm.2022.01031

あり

https://doi.org/10.1016/j.jth.2022.101405

あり

https://doi.org/10.1186/s12889-022-13331-5あり

https://doi.org/10.11197/jaih.37.51

あり

https://doi.org/10.2188/jea.je20220032

なし

https://doi.org/10.1007/s00595-022-02541-4

掲載予定

https://doi.org/10.3390/life12070966

あり

https://doi.org/10.24697/jaamkanto.43.3_72

あり

https://doi.org/10.1177/10105395221108594

あり

https://doi.org/10.35772/ghm.2022.01043

掲載予定

https://doi.org/10.2188/jea.JE20220056

あり

https://doi.org/10.1186/s41182-022-00435-2あり

https://doi.org/10.35772/ghm.2022.01011

掲載予定

https://doi.org/10.7189/jogh.12.03036

掲載予定

https://doi.org/10.51028/jjdisatmed.27.2_151あり

https://doi.org/10.3390/healthcare10071341

なし

https://doi.org/10.1128/mbio.00971-22なし

https://doi.org/10.1111/hepr.13819

なし

https://doi.org/10.1093/omcr/omac079あり

https://doi.org/10.1186/s12966-022-01327-8

なし

https://doi.org/10.3389/fpsyt.2022.781796

あり

https://doi.org/10.35772/ghm.2022.01030

あり

https://doi.org/10.35772/ghm.2022.01014

あり

https://doi.org/10.35772/ghm.2022.01009

掲載予定

https://doi.org/10.1007/s15010-022-01898-5あり

Kodani N, Ohsugi M.
264

2022/6/27

The patient-centered diabetes management during the COVID-19 pandemic.
Glob Health Med. 2022.
Okamoto S.

265

2022/6/6

State of emergency and human mobility during the COVID-19 pandemic in Japan.
J Transp Health. 2022:101405.
Wakabayashi M, Takada M, Kinjo A, Sugiyama Y, Iso H, Tabuchi T.

266

2022/6/13

Problem drinkers and high risk-taking behaviors under the stay-at-home policy of the COVID-19 emergency declaration.
BMC Public Health. 2022; 22(1):1173.
若林真美, 高橋麻奈, 磯博康.

2672022/6/16

太平洋島嶼国を事例としたCOVAXファシリティ等を通じたCOVID-19ワクチン支援.
国際保健学. 2022; 37(2):51-68
Yagome S, Sugiyama T, Inoue K, Igarashi A, Bouchi R, Ohsugi M, Ueki K, Goto A.

268

2022/6/11

Influence of the COVID-19 pandemic on overall physician visits and telemedicine use among patients with type 1 or type 2
diabetes in Japan.
J Epidemiol. 2022.
Sumiya R, Nagasaka S, Okamoto T, Ikeda T, Hojo M, Omagari N, Kokudo N.

269

2022/6/30

Clinical outcomes after tracheostomy in patients with coronavirus disease 2019: a single-center experience in Japan.
Surg Today. 2022 :1–5.
Terayama Y, Tomita N, Terada-Hirashima J, Uemura Y, Shimizu Y, Takeuchi JS, Takamatsu Y, Maeda K, Mikami A, Ujiie M,
Sugiura W.

270

2022/6/27

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine
for SARS-CoV-2 in Healthy Adults (KAPIVARA).
Life. 2022; 12(7):966.
杉山 茉祐, 関原 圭吾, 岡本 竜哉, 茂野 絢子, 柴崎 貴俊, 福田 有, 瓦 安迪, 木村 昭夫.

2712022/6/30

デクスメデトミジンにより洞調律のまま心停止をきたした重症COVID-19の1例.
日本救急医学会関東地方会雑誌. 2022; 43(3):72-75.
Nomura S, Kisugi N, Endo K, Omori T.

272

2022/6/30

Parenting, Social Isolation, and Loneliness Among New Parents During the COVID-19 Pandemic in Japan: A Pilot Study.
Asia Pac J Public Health. 2022:10105395221108594.
Yamanaka J, Takasago S, Horigome A, Hayashi M, Matsunashi S, Shioda S, Tanaka M, Seki J, Kaneshige M, Akamatsu T,

273

2022/7/7

Uryu H, Mochizuki S, Goishi K, Shichino H.Adapting pediatric health care responses to the COVID-19 pandemic in Japan: aclinical perspective.
Glob Health & Med. 2022.
Matsushita Y, Yokoyama T, Hayakawa K, Matsunaga N, Ohtsu H, Saito S, Terada M, Suzuki S, Morioka S, Kutsuna S,
Tsuzuki S, Hara H, Kimura A, Ohmagari N.

274

2022/7/16

We should pay more attention to sex differences to predict the risk of severe COVID-19: men have the same risk of worse
prognosis as women more than 10 years older.
J Epidemiol. 2022 .
Moriyama J, Ito T, Doi M, Seino K, Luong DH, Iwamoto A, Murakami H.

275

2022/7/12

Enhancing hospital quality management and patient safety in Vietnam: a technical assistance project utilizing online
solutions during COVID-19 pandemic.
Trop Med Health. 2022; 50(1):45.
Matsunaga F, Kono Y, Kitamura H, Terashima M.

277

2022/7/12

The role of radiologic technologists during the COVID-19 pandemic.
Glob Health Med. 2022.
Terada M, Tsuzuki S, Asai Y, Saito S, Ohmagari N. Considerations and concerns regarding the readiness to remove face276

2022/6/21

coverings.
J Glob Health. 2022; 12:03036.
井手 聡, 森岡 慎一郎, 須貝 和則, 木村 昭夫, 梶尾 裕, 大曲 貴夫, 杉山 温人.

278

2022/7/13

自院で設定したフェーズに応じた新型コロナウイルス（COVID-19）対応の経験.
日本災害医学会雑誌. 2022; 27(2):151-158.
Aouissi HA, Kechebar MSA, Ababsa M, Roufayel R, Neji B, Petrisor AI, Hamimes A, Epelboin L, Ohmagari N.

279

2022/7/19

The Importance of Behavioral and Native Factors on COVID-19 Infection and Severity: Insights from a Preliminary CrossSectional Study.
Healthcare (Basel). 2022; 10(7):1341.
Nishitsuji H, Iwahori S, Ohmori M, Shimotohno K, Murata T.

280

2022/7/20

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation.
mBio. 2022: e0097122.
Ashraf Hussain MR, Hiebert L, Sugiyama A, Ouoba S, E B, Ko K, Akita T, Kaneko S, Kanto T, Ward JW, Tanaka J.

281

2022/7/21

Effect of COVID-19 on hepatitis B and C virus countermeasures: Hepatologist responses from nationwide survey in Japan.
Hepatol Res. 2022.
Hirata K, Watanabe K, Sasaki T, Yoshimasu T, Shimomura A, Ando N, Yanagawa Y, Mizushima D, Teruya K, Kikuchi Y, Oka
S, Tsukada K.

282

2022/7/26

Unmasking latent extrapulmonary tuberculosis with newly diagnosed HIV-1 infection in a COVID-19 patient with prolonged
fever.
Oxf Med Case Reports. 2022; 2022(7):omac079.
Xiang M, Liu Y, Yamamoto S, Mizoue T, Kuwahara K.

283

2022/7/26

Association of Changes of lifestyle behaviors before and during the COVID-19 pandemic with mental health: a longitudinal
study in children and adolescents.
Int J Behav Nutr Phys Act. 2022; 19(1):92.
Morioka S, Tan BH, Kikuchi H, Asai Y, Suzuki T, Ashida S, Kutsuna S, Saito S, Hayakawa K, Tan TT, Kodama E, Ohmagari
N.

2842022/4/28

Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient
Care in Singapore and Japan.
Front Psychiatry. 2022; 13:781796.
Sato L, Ishikane M, Okumura N, Iwamoto N, Hayakawa K, Iseki K, Hara H, Ohmagari N.

285

2022/8/6

A novel anticoagulation treatment protocol using unfractionated heparin for coronavirus disease 2019 patients in Japan,
2022.
Glob Health Med. 2022.
Tamura T, Inoue N, Murakami H.

286

2022/8/6

International technical cooperation to low- and middle-income countries during the COVID-19 pandemic.
Glob Health Med. 2022.
Kobayashi K, Kimura A, Sasaki R, Hayakawa K, Ohmagari N, Sugiura Y, Sugiyama H, Kokudo N.

287

2022/8/6

Actual situation of handling Tokyo 2020 Games-related patients at a designated hospital during COVID-19 pandemic.
Glob Health Med. 2022.
Yamamoto S, Tanaka A, Oshiro Y, Inamura N, Mizoue T, Ohmagari N; for SARS-CoV-2 Seroepidemiological Study among288

2022/8/4

NCGM staff.
Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine.
Infection. 2022.

13

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/j.ypmed.2022.107123

あり

https://doi.org/10.1038/s41598-022-17071-9あり

https://doi.org/10.1016%2Fj.jiac.2022.08.004

なし

https://doi.org/10.1128/msphere.00086-22

掲載予定

https://doi.org/10.1371/journal.pone.0272856

あり

https://doi.org/10.1016/j.jinf.2022.08.015

あり

https://doi.org/10.1016/j.jhin.2022.08.003

あり

https://doi.org/10.1093/cid/ciac665

なし

https://doi.org/10.7883/yoken.jjid.2021.896あり

https://doi.org/10.1002/jja2.12739

あり

https://doi.org/10.1038/s41598-022-18945-8

なし

https://doi.org/10.1111/jgh.16001

なし

Yamamoto S, Tanaka A, Ohmagari N, Yamaguchi K, Ishitsuka K, Morisaki N, Kojima M, Nishikimi A, Tokuda H, Inoue M,
Tanaka S, Umezawa J, Okubo R, Nishimura K, Konishi M, Miyo K, Mizoue T.
289

2022/7/1

Use of heated tobacco products, moderate alcohol drinking, and anti-SARS-CoV-2 IgG antibody titers after BNT162b2
vaccination among Japanese healthcare workers.
Prev Med. 2022; 161:10.
Amano M, Otsu S, Maeda K, Uemura Y, Shimizu Y, Omata K, Matsuoka M, Shimada S, Mitsuya H.

2902022/8/8

Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha,Beta, Gamma, Delta, and Kappa variants.
Sci Rep. 2022; 12(1):13524.
Shoji K, Akiyama T, Tsuzuki S, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Ohmagari N.

291

2022/8/10

Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period.
J Infect Chemother. 2022:S1341-321X(22)00230-6.
Ueki H, Ujie M, Komori Y, Kato T, Imai M, Kawaoka Y.

292

2022/8/10

Effectiveness of HEPA Filters at Removing Infectious SARS-CoV-2 from the Air.
mSphere. 2022:e0008622.
Manandhar Shrestha R, Inoue Y, Fukunaga A, Hoang DV, Yamamoto S, Miki T, Konishi M, Ohmagari N, Mizoue T.

293

2022/8/11

Infection prevention practices and its associated factors among hospital workers in a national medical center designatedfor COVID-19 in Tokyo, Japan.
PLoS One. 2022; 17(8):e0272856.
Mizoue T, Yamamoto S, Konishi M, Oshiro Y, Inamura N, Nemoto T, Ozeki M, Horii K, Okudera K, Sugiyama H, Aoyanagi N,
Sugiura W, Ohmagari N.

294

2022/8/26

Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of theOmicron variants.
J Infect. 2022:S0163-4453(22)00480-7.
Yamamoto S, Mizoue N, Mizoue T, Konishi M, Horii K, Sugiyama H, Ohmagari N.

295

2022/8/26

Living with school-age children and absence among staff of a tertiary hospital during the Omicron epidemic in Tokyo.
J Hosp Infect. 2022:S0195-6701(22)00257-2.
Uchikoba S, Yamada G, Tsuzuki S.

296

2022/8/26

Methodological concerns regarding a retrospective study with real-world data on Paxlovid® in Israel.
Clin Infect Dis. 2022:ciac665.
Horigome A, Yamanaka J, Takasago S, Iwamoto N, Saito T, Shichino H.

297

2022/8/31

The first case of a child infected with SARS-CoV-2 Omicron variant in Japan, December 2021.
Jpn J Infect Dis. 2022.
船登 有未, 松田 航, 植村 樹, 小林 憲太郎, 佐々木 亮 , 岡本 竜哉, 木村 昭夫.

2982022/9/1

重症COVID–19肺炎の急性期の循環動態は比較的安定している～単施設・症例対照研究～.
日救急医会誌. 2022; 33: 474-81.
Fujita R, Kurosu H, Norizuki M, Ohishi T, Zamoto-Niikura A, Iwaki M, Mochida K, Takagi H, Harada T, Tsushima K,

299

2022/9/2

Matsumoto T, Hanaki KI, Sugai M, Yamagishi T.
Potential risk of SARS-CoV-2 infection among people handling linens used by COVID-19 patients before and after washing.
Sci Rep. 2022; 12(1):14994.
Shiga H, Kakuta Y, An K, Abe Y, Fujimaki S, Shimoyama Y, Naito T, Moroi R, Kuroha M, Khor SS, Kawai Y, Tokunaga K,

302

2022/9/6

Kinouchi Y, Masamune A.
Response to COVID19 vaccines is reduced in patients with inflammatory bowel disease, but improved with additional dose.
J Gastroenterol Hepatol. 2022.
Goto R, Kawakami H, Horiuchi Y, Chikada A, Yasuda T, Suzuki T, Miyazato Y, Ishikane M, Kishino Y, Miyazaki H, Igari T,

300

2022/9/6

Katano H, Suzuki T, Murayama S, Arai N.

https://doi.org/10.2169/internalmedicine.9726-

An Autopsy Report of a Case with Cerebral Infarction Complicated by Coronavirus Disease 2019 Infection.

22ありIntern Med. 2022.
Kuse N, Zhang Y, Chikata T, Nguyen HT, Oka S, Gatanaga H, Takiguchi M.
301

2022/9/6

Long-term memory CD8+ T cells specific for SARS-CoV-2 in individuals who received the BNT162b2 mRNA vaccine.

https://doi.org/10.1038/s41467-022-32989-4

なし

https://doi.org/10.1016/j.jiac.2022.08.026あり

https://doi.org/10.1016/j.jiac.2022.09.001あり

https://doi.org/10.35772/ghm.2022.01020

なし

Nat Commun. 2022; 13(1):5251.
Okumura N, Saito S, Takamatsu Y, Takeuchi JS, Asai Y, Sanada M, Iwamoto N, Kenji M, Mitsuya H, Ohmagari N.
303

2022/9/5

Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination.
J Infect Chemother. 2022:S1341-321X(22)00252-5.
Nomoto H, Yamamoto K, Isaka E, Miyazato Y, Suzuki T, Maruki T, Yamada G, Kamegai K, Akiyama Y, Ide S, Kurokawa M,

304

2022/9/8

Moriya A, Mezaki K, Yagi S, Nojima H, Yamakawa K, Ohmagari N.
Potential usage of anterior nasal sampling in clinical practice with three rapid antigen tests for SARS-CoV-2.
J Infect Chemother. 2022:S1341-321X(22)00254-9.
Honda A, Tamura T, Baba H, Kodoi H, Noda S.

305

2022/9/11

How should support for hospital staff during health shocks be improved? A discussion from Japan's experience during the
COVID-19 pandemic.
Glob Health Med. 2022.
Kimura M, Uemura Y, Omagari N, Ikeda M, Sugiura W.

306

2021/10/4

https://geneft.com/article/correlation-between-

Correlation between asymptomatic cases and the incidence of COVID-19

asymptomatic-cases-and-the-incidence-of-

in Japan.

あり

covid-19-in-japan

Epidem Pub Hel Res.2021; 1(2):1-3
Karako K, Song P, Chen Y, Karako T.
3072022/9/12

An average of nearly 200,000 new infections per day over a six-week period: What is the impact of such a severe COVID-19
pandemic on the healthcare system in Japan?

https://doi.org/10.5582/bst.2022.01390

あり

https://doi.org/10.1038/s41598-022-19581-yあり

https://doi.org/10.1016/j.jiac.2022.09.005

なし

https://doi.org/10.3390/ijerph191912086

あり

https://doi.org/10.1093/infdis/jiac209

掲載予定

Biosci Trends. 2022.
Takeuchi JS, Fukunaga A, Yamamoto S, Tanaka A, Matsuda K, Kimura M, Kamikawa A, Kito Y, Maeda K, Ueda G, Mizoue
T, Ujiie M, Mitsuya H, Ohmagari N, Sugiura W.
308

2022/9/14

SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal
study.
Sci Rep. 2022; 12(1):15447.
Shoji K, Tsuzuki S, Akiyama T, Matsunaga N, Asai Y, Suzuki S, Iwamoto N, Funaki T, Yamada M, Ozawa N, Yamaguchi K,
Miyairi I, Ohmagari N.

309

2022/9/11

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern
predominant periods.
J Infect Chemother. 2022:S1341-321X(22)00264-1.
Wakabayashi M, Sugiyama, Y, Takada, M, Kinjo, A, Iso, H, Tabuchi, T.

310

2022/9/24

Loneliness and Increased Hazardous Alcohol Use: Data from a Nationwide Internet Survey with 1-Year Follow-Up.
Int J Environ Res Public Health. 2022:19, 12086.
Amano M, Maeda K, Tsuchiya K, Shimada S, Mitsuya H.

311

2022/5/17

Third-dose BNT162b2 vaccination elicits markedly high-level SARS-CoV-2-neutralizing antibodies in vaccinees who poorly
responded to second dose in Japan.
J Infect Dis. 2022:jiac209.

142024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1053/j.gastro.2022.09.024

掲載予定

https://doi.org/10.2196/37426

掲載予定

https://doi.org/10.1016/j.lanwpc.2022.100600

あり

https://doi.org/10.35772/ghm.2022.01010

あり

https://doi.org/10.35772/ghm.2022.01019

あり

https://doi.org/10.35772/ghm.2022.01028

あり

https://doi.org/10.1111/inm.13069

なし

https://doi.org/10.1016/j.cmi.2022.09.009

なし

https://doi.org/10.1248/bpb.b22-00503

あり

https://doi.org/10.1128/spectrum.02716-22あり

https://doi.org/10.1002/ccr3.6431

あり

https://doi.org/10.3389/fmed.2022.1052921

あり

https://doi.org/10.1186/s40792-022-01553-z

あり

https://doi.org/10.7189/jogh.12.03073

あり

https://doi.org/10.5582/ddt.2022.01068

掲載予定

https://doi.org/10.1128/spectrum.03490-22あり

https://doi.org/10.1016/j.isci.2022.105365

なし

https://doi.org/10.1371/journal.pone.0276774

なし

https://doi.org/10.1002/hsr2.922あり

https://doi.org/10.1111/ped.15407

掲載予定

https://doi.org/10.1017/s0950268822001686

あり

https://doi.org/10.1128/jvi.01551-21

掲載予定

https://doi.org/10.35772/ghm.2022.01012

あり

https://doi.org/10.35772/ghm.2022.01053

あり

Nagata N, Takeuchi T, Masuoka H, Aoki R, Ishikane M, Iwamoto N, Sugiyama M, Suda W, Nakanishi Y, Terada-Hirashima J,
Kimura M, Nishijima T, Inooka H, Miyoshi-Akiyama T, Kojima Y, Shimokawa C, Hisaeda H, Zhang F, Yeoh YK, Ng SC,
312

2022/9/22

Uemura N, Itoi T, Mizokami M, Kawai T, Sugiyama H, Ohmagari N, Ohno H.
Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications.
Gastroenterology. 2022 :S0016-5085(22)01081-2.
Terada-Hirashima J, Izumi S, Katagiri D, Uemura Y, Mikami A, Sugiura W, Abe S, Azuma A, Sugiyama H.

313

2022/9/20

Efficacy and Safety of Direct Hemoperfusion using Polymyxin B-Immobilized Polystyrene Column (PMX-DHP) for COVID19 Patients: Exploratory Study Protocol.
JMIR Res Protoc. 2022.
Yamaguchi T, Iwagami M, Ishiguro C, Fujii D, Yamamoto N, Sakai H, Tsuboi T, Umeda H, Kinoshita N, Iguchi T, Oka A,

314

2022/9/20

Morio T, Nakai K, Hayashi S, Tsuruta S. Updated report of COVID-19 vaccine safety monitoring in Japan: Booster shots andpaediatric vaccinations.
Lancet Reg Health West Pac. 2022; 27:100600.
Motohashi A.

316

2022/9/26

The development of SARS-CoV-2 PCR testing methods at a designated medical institution for specific infectious diseases
in Japan.
Glob Health Med. 2022.
Sone H, Ogawa H, Miyaki R, Kato O.

315

2022/9/26

Efforts of a Psychiatric Liaison Team in a ward with patients with severe coronavirus disease 2019.
Glob Health Med. 2022.
Tamai Y, Arai N, Fujitani M, Kanayama S, Inoue M, Hara T.

317

2022/9/30

Stroke treatment during the COVID-19 pandemic.
Glob Health Med. 2022.
Narita Z, Okubo R, Sasaki Y, Takeda K, Takao M, Komaki H, Oi H, Mizoue T, Miyama T, Kim Y.

318

2022/9/29

COVID-19-related discrimination, PTSD symptoms, and psychological distress in healthcare workers.
Int J Ment Health Nurs. 2022.
Koga M, Iwatsuki-Horimoto K, Kikuchi T, Yamayoshi S, Kawaoka Y, Yotsuyanagi H. Previous Omicron infection may be

319

2022/9/28

protective against reinfection with Omicron variant BA.5 for at least 5 months.
Clin Microbiol Infect. 2022:S1198-743X(22)00495-5.
Hayashi Y, Matsuda K, Tanigawa K, Tanikawa T, Maeda K, Tsuchiya K.

320

2022/10/1

Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection.
Biol Pharm Bull. 2022; 45(10):1559-1563.
Takamatsu Y, Omata K, Shimizu Y, Kinoshita-Iwamoto N, Terada M, Suzuki T, Morioka S, Uemura Y, Ohmagari N, Maeda

321

2022/10/11

322

2022/10/11

K, Mitsuya H.
SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response.
Microbiol Spectr. 2022:e0271622.
Kurozumi A, Hara H, Nagai R, Hiroi Y.
Acute myocardial infarction immediately after second vaccination for coronavirus disease 2019.
Clin Case Rep. 2022; 10(10):e6431.
Minamimoto R.

323

2022/10/29

Oncology and cardiology positron emission tomography/computed tomography faced with COVID-19: A review of available
literature data.
Front. Med. 2022.
Sugita A, Inagaki FF, Takemura N, Nakamura M, Ito K, Mihara F, Yamamoto K, Morioka S, Kokudo N.

324

2022/10/20

Liver resection in a patient with persistent positive PCR test for coronavirus disease 2019 (COVID-19): a case report.
Surg Case Rep. 2022; 8(1):200.
Karako K, Song P, Chen Y, Karako T.

325

2022/10/14

COVID-19 in Japan during 2020-2022: Characteristics, responses, and implications for the health care system.
J Glob Health. 2022; 12:03073.
Terada-Hirashima J, Suzuki M, Tsujimoto Y, Hamamoto Y, Uemura Y, Tsushima K, Inoue H, Komatsu S, Saito Z, Tsuzuki R,
Okamoto M, To Y, Moriya K, Yoshizawa S, Tanaka M, Muto T, Mikami A, Takasaki J, Izumi S, Ohmagari N, Hojo M, Sugiura326

2022/10/26

W, Sugiyama H.
Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial.
Drug Discov Ther. 2022 .
Higashi-Kuwata N, Yabe SG, Fukuda S, Nishida J, Tamura-Nakano M, Hattori SI, Okochi H, Mitsuya H.

327

2022/10/31

Generation of Angiotensin-Converting Enzyme 2/Transmembrane Protease Serine 2-Double-Positive Human Induced
Pluripotent Stem Cell-Derived Spheroids for Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Drug Evaluation.
Microbiol Spectr. 2022:e0349022.
Tsuji K, Ishii T, Kobayakawa T, Higashi-Kuwata N, Azuma C, Nakayama M, Onishi T, Nakano H, Wada N, Hori M, Shinohara
K, Miura Y, Kawada T, Hayashi H, Hattori SI, Bulut H, Das D, Takamune N, Kishimoto N, Saruwatari J, Okamura T, Nakano

328

2022/11/1

K, Misumi S, Mitsuya H, Tamamura H.
Potent and biostable inhibitors of the main protease of SARS-CoV-2.
iScience. 2022 :105365.
Uruma Y, Manabe T, Fujikura Y, Iikura M, Hojo M, Kudo K. Effect of asthma, COPD, and ACO on COVID-19: A systematic

329

2022/11/1

review and meta-analysis.
PLoS One. 2022; 17(11):e0276774.
Shimotake Y, Mbelambela EPS, Muchanga SMJ, Villanueva AF, Siburian MD, Shimomoto R, Ikeuchi K, Matsunaga Y,
Minami M, Iiyama T, Suganuma N.

330

2022/11/3

Knowledge, attitude, perception, and factors associated with the risk perception of COVID-19 among nursing college
students in Japanese universities: A cross-sectional study.
Health Sci Rep. 2022; 5(6):e922.
Ikeda S, Benzi E, Hensch LA, Devaraj S, Hui SK, Gandhi M, Fox KA, Teruya J, Munoz FM.

331

2022/11/3

Convalescent plasma in hospitalized pediatric and obstetric COVID-19 patients.
Pediatr Int. 2022 :e15407.
Tsuzuki S, Akiyama T, Matsunaga N, Ohmagari N.

332

2022/11/3

Association between physical activity status and severity of COVID-19 in older adults.
Epidemiol Infect. 2022:1-29.
Takamatsu Y, Imai M, Maeda K, Nakajima N, Higashi-Kuwata N, Iwatsuki-Horimoto K, Ito M, Kiso M, Maemura T, Takeda
Y, Omata K, Suzuki T, Kawaoka Y, Mitsuya H.

3332022/2/23

Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian
Hamsters.
J Virol. 2022; 96(4):e0155121.
Sato M, Fukaya T, Ogawa T, Nunose N, Hosaka S.

334

2022/9/26

The role of clinical engineers in the coronavirus disease 2019 pandemic.
Glob Health Med. 2022; 4(5):294-295.
Uchihara M, Kodani N, Bouchi R, Saito S, Miyazato Y, Sugimoto H, Umamoto K, Kobayashi M, Ihana-Sugiyama N, Ohsugi
M, Tanabe A, Ueki K, Takasaki J, Hojo M, Kajio H.

335

2022/11/20

Glycemic control using intermittently scanned continuous glucose monitoring in patients with diabetes requiring
methylprednisolone therapy for severe COVID-19.
Glob Health Med. 2022.

15

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/j.isci.2022.105596

なし

https://doi.org/10.1093/ofid/ofac638

なし

https://doi.org/10.1186/s13034-022-00525-3

なし

https://doi.org/10.35772/ghm.2022.01021

あり

https://doi.org/10.1093/ofid/ofac636あり

https://doi.org/10.1016/j.ijid.2022.10.001あり

https://doi.org/10.35772/ghmo.2022.01007

あり

https://doi.org/10.34325/jsbpcc.13.1_52あり

https://doi.org/10.1371/journal.ppat.1010970

なし

https://doi.org/10.7189/jogh.12.05047

あり

https://doi.org/10.7759/cureus.32155

掲載予定

https://doi.org/10.1016/s1473-3099(22)00816-7

掲載予定

https://doi.org/10.1016/j.jiac.2022.12.003

あり

https://doi.org/10.3390/vaccines10122142あり

https://doi.org/10.35772/ghm.2022.01042

掲載予定

https://doi.org/10.35772/ghm.2022.01071

あり

https://doi.org/10.35772/ghm.2022.01056

あり

https://doi.org/10.1186/s13098-022-00918-6

あり

https://doi.org/10.1016/j.jiac.2022.08.007

あり

https://doi.org/10.5582/bst.2022.01526

なし

https://doi.org/10.1002/dmrr.3606

あり

https://doi.org/10.1111/irv.13090

掲載予定

https://doi.org/10.1016/j.jiph.2022.12.014あり

https://doi.org/10.1016/j.transci.2022.103638

あり

https://doi.org/10.24697/jaamkanto.43.4_101

あり

Takeshita M, Fukuyama H, Kamada K, Matsumoto T, Makino-Okamura C, Uchikubo-Kamo T, Tomabechi Y, Hanada K,
Moriyama S, Takahashi Y, Ishigaki H, Nakayama M, Nguyen CT, Kitagawa Y, Itoh Y, Imai M, Maemura T, Furusawa Y, Ueki
336

2022/11/15

H, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Kawaoka Y, Shirouzu M, Ishii M, Saya H, Kondo Y, Kaneko Y, Suzuki K,
Fukunaga K, Takeuchi T; Keio Donner Project.
Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.
iScience. 2022:105596.
Baba H, Ikumi S, Aoyama S, Ishikawa T, Asai Y, Matsunaga N, Ohmagari N, Kanamori H, Tokuda K, Ueda T, Kawakami E.

338

2022/11/24

Statistical analysis of mortality rates of COVID-19 patients in Japan across the 4C mortality score risk groups, age groups,
and epidemiological waves: A report from the nationwide COVID-19 cohort.
Open Forum Infect Dis.2022; ofac638.
Goto R, Piedvache A, Hangai M, Yamaoka Y, Sampei M, Sawada N, Okubo Y, Tanaka K, Morisaki N, Hosozawa M.

339

2022/11/23

Time trends in emotional well-being and self-esteem in children and adolescents during the COVID-19 pandemic.
Child Adolesc Psychiatry Ment Health. 2022; 16(1):89.
Yokoi C, Yanai Y, Suzuki K, Akazawa N, Yamamoto N, Akiyama J.

337

2022/11/27

Gastrointestinal endoscopy trends in a designated hospital for specified infectious diseases in Japan during the dawn ofthe "living with COVID-19" era.
Glob Health Med. 2022.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.

340

2022/11/24

Effectiveness of a third dose of COVID-19 mRNA vaccine during the Omicron BA.1- and BA.2-predominant periods inJapan: The VENUS Study.
Open Forum Infect Dis.2022; ofac636.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.

341

2022/10/8

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron
variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Int J Infect Dis. 2022; 125:58-60.
Hattori K, Eriguchi A, Omori M, Nagata O.

342

2022/11/28

Visualization of aerosol spread using a smoke tester during tracheal intubation performed in an operating room.
GHM Open. 2022.
片桐大輔.

343

2022/12/1

COVID-19におけるPMX-DHP.
日本急性血液浄化学会雑誌. 2022 ;13(1):52-53.
Boon ACM, Darling TL, Halfmann PJ, Franks J, Webby RJ, Barouch DH, Port JR, Munster VJ, Diamond MS, Kawaoka Y.

344

2022/12/2

Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters.
PLoS Pathog. 2022; 18(12):e1010970.
Tsuzuki S, Asai Y, Ibuka Y, Nakaya T, Ohmagari N, Hens N, Beutels P.

345

2022/12/3

Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games.
J Glob Health. 2022; 12:05047.
Tamura A, Murakami M, Jinta T, Okamoto H.

346

2022/12/3

Isolation of Patients With Bacterial Pneumonia Suspected of COVID-19 Leads to Prolonged Hospitalization.
Cureus. 2022; 14(12):e32155.
Uraki R, Ito M, Furusawa Y, Yamayoshi S, Iwatsuki-Horimoto K, Adachi E, Saito M, Koga M, Tsutsumi T, Yamamoto S,

347

2022/12/7

Otani A, Kiso M, Sakai-Tagawa Y, Ueki H, Yotsuyanagi H, Imai M, Kawaoka Y.
Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB.
Lancet Infect Dis. 2022:S1473-3099(22)00816-7.
Tomidokoro D, Asai Y, Hayakawa K, Kutsuna S, Terada M, Sugiura W, Ohmagari N, Hiroi Y.

348

2022/12/13

Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary,secondary, and tertiary care facilities.
J Infect Chemother. 2022:S1341-321X(22)00326-9.
Islam Z, Yamamoto S, Mizoue T, Oshiro Y, Inamura N, Nemoto T, Konishi M, Ozeki M, Sugiura W, Ohmagari N.

349

2022/12/14

Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine
Recipients.
Vaccines. 2022; 10(12):2142.
Yamada K, Hara T, Sato K, Koyama Y, Kato D, Nohara K, Enomoto N, Yagi S, Kitagawa D, Takemura N, Nagasaka S,

350

2022/12/17

Kiyomatsu T, Kokudo N.
Infection control of COVID-19 in operating theaters in a designated hospital for specified infectious diseases in Japan.
Glob Health Med. 2022.
Kamegai K, Hayakawa K.

351

2022/12/17

Towards the light at the end of the tunnel: Changes in clinical settings and political measures regarding COVID-19 from2021, and future perspectives in Japan.
Glob Health Med. 2022.
Saeki S, Iwata M, Tomizawa R, Minamitani K.

352

2022/12/15

Challenges and the potential of promoting remote medical interpreting during COVID-19.
Glob Health Med. 2022.
Van Hoang D, Yamamoto S, Fukunaga A, Inoue Y, Mizoue T, Ohmagari N.

353

2022/10/13

Metabolic syndrome and the immunogenicity of Pfizer-BioNTech vaccine: a cross-sectional study in Japanese healthcare
workers.
Diabetol Metab Syndr. 2022; 14(1):149.
Morioka S, Tsuzuki S, Suzuki M, Terada M, Akashi M, Osanai Y, Kuge C, Sanada M, Tanaka K, Maruki T, Takahashi K, Saito

354

2022/8/11

S, Hayakawa K, Teruya K, Hojo M, Ohmagari N.
Post COVID-19 condition of the Omicron variant of SARS-CoV-2.
J Infect Chemother. 2022; 28(11):1546-1551.
Karako K, Song P, Chen Y, Karako T.

356

2022/12/25

Trends in managing COVID-19 from an emerging infectious disease to a common respiratory infectious disease: What are
the subsequent impacts on and new challenges for healthcare systems?
Biosci Trends. 2022; 16(6):381-385.
Islam Z, Yamamoto S, Mizoue T, Oshiro Y, Inamura N, Konishi M, Ozeki M, Sugiura W, Ohmagari N.

355

2022/12/23

Dyslipidemia and SARS-CoV-2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among
healthcare workers in Japan.
Diabetes Metab Res Rev. 2022:e3606.
Takashita E, Watanabe S, Hasegawa H, Kawaoka Y.

357

2022/12/25

Are twindemics occurring?
Influenza Other Respi Viruses. 2023;17(1):e13090.
Asai Y, Tsuzuki S, Matsunaga N, Ohmagari N.

358

2022/12/26

Regional trends in the use of steroids and favipiravir for COVID-19 treatment.
J Infect Public Health. 2022; 16(2):206-213.
Inada M, Togano T, Terada M, Shiratori K, Tsuzuki S, Takamatsu Y, Saito S, Hangaishi A, Morioka S, Kutsuna S, Maeda K,

359

2022/12/29

Mitsuya H, Ohmagari N.
Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma.
Transfus Apher Sci. 2022:103638.
山本 裕記, 船登 有未, 小林 憲太郎, 佐々木 亮, 木村 昭夫.

360

2022/12/28

救急外来で偶発的に診断した新型コロナウイルス感染症の検討.
日救急医会関東誌. 2022; 43(4):101-106.

16

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1007/s12144-022-04177-6なし

https://doi.org/10.14740/jcgo824なし

https://doi.org/10.35772/ghm.2022.01018

あり

https://doi.org/10.35772/ghm.2022.01054

あり

https://doi.org/10.1128/msphere.00411-22

掲載予定

https://doi.org/10.3390/jcm12030838

あり

https://doi.org/10.1016/j.jpsychires.2023.01.025

なし

https://doi.org/10.1002/ehf2.14295

なし

https://doi.org/10.1111/jdi.13979

あり

https://doi.org/10.35772/ghm.2023.01002

あり

https://doi.org/10.35772/ghm.2022.01060

なし

https://doi.org/10.1016/S1473-3099(23)00070-1

あり

https://doi.org/10.1186/s41100-023-00465-4

なし

https://doi.org/10.1016/j.puhe.2023.01.008

あり

https://doi.org/10.1038/s41598-023-29740-4あり

https://doi.org/10.1016/j.ijid.2023.01.023あり

https://doi.org/10.1016/j.jhin.2023.01.018あり

https://doi.org/10.1016/j.jmh.2023.100169

掲載予定

https://doi.org/10.1080/23288604.2023.2175415

なし

https://doi.org/10.1080/20477724.2023.2176642

なし

https://doi.org/10.1016/j.jiac.2023.02.006

あり

Morishita K, Katase K, Ishikane M, Otomo Y.
361

2022/12/31

Motivating factors for frontline healthcare workers during the COVID-19 pandemic: A survey in Japan.
Curr Psychol. 2022:1-9.
Miyoshi A, Ueda Y, Yagi A, Kimura T, Kobayashi E, Hiramatsu K, Nakagawa S, Tabuchi T, Hosokawa Y, Okawa S, Kimura T.

362

2022/12/30

363

2023/1/7

How the COVID-19 Pandemic Changed a New Mother’s Sense of Loneliness, and Who Was Key to Helping Them ThroughIt.
J Clin Gynecol Obstet. 2022; 11(4):101-107.
Nagata O, Hattori K, Maehara Y.
Theoretical and evidence-based infection control during general anesthesia in the COVID-19 pandemic.
Glob Health Med. 2023.
Katsuno T, Suzuki M, Morishita M, Kawajiri K, Saito S, Horikawa Y, Ueki Y, Yamaguchi Y, Takumida H, Watanabe H, Morita
C, Tsukada A, Kusaba Y, Tsujimoto Y, Ishida A, Sakamoto K, Hashimoto M, Terada J, Takasaki J, Izumi S, Hojo M,3642023/1/13

Sugiyama H.
High-flow nasal cannula for severe COVID-19 patients in a Japanese single-center, retrospective, observational study: 1
year of clinical experience.
Glob Health Med. 2023.
Iwatsuki-Horimoto K, Ueki H, Ito M, Nagasawa S, Hirata Y, Hashizume K, Ushiwata K, Iwase H, Makino Y, Ushiku T,

365

2023/1/10

Akitomi S, Imai M, Saitoh H, Kawaoka Y.
SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters.
mSphere. 2023:e0041122.
Katagiri D, Kikuchi K.

366

2023/1/20

The Impact and Treatment of COVID-19 in Hemodialysis Patients.
J. Clin. Med. 2023; 12(3):838.
Narita Z, Okubo R, Sasaki Y, Takeda K, Ohmagari N, Yamaguchi K, Morisaki N, Sampei M, Ishitsuka K, Kojima M,

367

2023/1/19

Nishimura K, Inoue M, Yamamoto S, Konishi M, Miyo K, Mizoue T.
Association of COVID-19-related discrimination with subsequent depression and suicidal ideation in healthcare workers.
J Psychiatr Res. 2023; 159:153-158.
Tadokoro T, Ohta-Ogo K, Ikeda Y, Sugiyama M, Katano H, Hatakeyama K, Matsumoto M, Tashiro H.

368

2023/1/24

COVID-19-associated myocardial injury: A case report.
ESC Heart Fail. 2023.
Uchihara M, Sugiyama T, Bouchi R, Matsunaga N, Asai Y, Gatanaga H, Ohsugi M, Ohmagari N, Kajio H, Ueki K.

369

2023/1/27

Association of acute-to-chronic glycemic ratio and outcomes in patients with COVID-19 and undiagnosed diabetes
mellitus: A retrospective nationwide cohort study.
J Diabetes Investig. 2023.
Nozaki I, Hachiya M, Ikeda C.

370

2023/2/1

COVID-19 vaccination program in Cambodia: Achievements and remaining challenges.
Glob Health Med. 2023.
Shimbashi R, Shiino T, Ainai A, Moriyama S, Arai S, Morino S, Takanashi S, Arashiro T, Suzuki M, Matsuzawa Y, Kato K,
Hasegawa M, Koshida R, Kitaoka M, Ueno T, Shimizu H, Yuki H, Takeda T, Nakamura-Uchiyama F, Takasugi K, Iida S,
Shimada T, Kato H, Fujimoto T, Iwata-Yoshikawa N, Sano K, Yamada S, Kuroda Y, Okuma K, Nojima K, Nagata N, Fukushi

371

2023/2/5

S, Maeda K, Takahashi Y, Suzuki T, Ohnishi M, Tanaka-Taya K.
Specific COVID-19 risk behaviors and the preventive effect of personal protective equipment among healthcare workers inJapan.
Glob Health Med. 2023.
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Furusawa Y, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S,

372

2023/2/8

Adachi E, Saito M, Tsutsumi T, Otani A, Kikuchi T, Yotsuyanagi H, Halfmann PJ, Pekosz A, Kawaoka Y.
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate.
Lancet Infect Dis. 2023:S1473-3099(23)00070-1.
Fukuzaki N, Suzuki Y, Uchida J, Nakajima T, Yamamoto S, Imamura K, Yoshikoshi S, Harada M, Matsuzawa R, Kamiya K,
Matsunaga A.

373

2023/2/10

Changes in body composition of patients undergoing hemodialysis during the coronavirus disease 2019 pandemic: aretrospective longitudinal study.
Ren Replace Ther. 2023; 9(1):12.
Morioka S, Tsuzuki S, Maruki T, Terada M, Miyazato Y, Kutsuna S, Saito S, Shimanishi Y, Takahashi K, Sanada M, Ashida3742023/2/13

S, Akashi M, Kuge C, Osanai Y, Tanaka K, Suzuki M, Hayakawa K, Ohmagari N.
Epidemiology of post-COVID conditions beyond 1 year: a cross-sectional study.
Public Health. 2023; 216:39-44.
Suzuki T, Morioka S, Yamamoto K, Saito S, Iida S, Teruya K, Takasaki J, Hojo M, Hayakawa K, Kutsuna S, Miyamoto S,

375

2023/2/15

Ozono S, Suzuki T, Kodama EN, Ohmagari N.
Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula.
Sci Rep. 2023; 13(1):2669.
Yamamoto S, Matsuda K, Maeda K, Horii K, Okudera K, Oshiro Y, Inamura N, Takeuchi JS, Konishi M, Ozeki M, Mizoue T,
Sugiyama H, Aoyanagi N, Mitsuya H, Sugiura W, Ohmagari N.

376

2023/1/22

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during theOmicron-predominant wave.
Int J Infect Dis. 2023; 128:347-354.
Li Y, Yamamoto S, Oshiro Y, Inamura N, Nemoto T, Horii K, Takeuchi JS, Mizoue T, Konishi M, Ozeki M, Sugiyama H,
Sugiura W, Ohmagari N.

377

2023/2/16

Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominanceperiods in Japan.
J Hosp Infect. 2023:S0195-6701(23)00044-0.
Fujita M, Kanda M, Kiyohara H, Ikeda S, Iwamoto A, Sudo K, Teshima Y, Nii M, Murata Y, Kato J, Komatsu A, Yumino A,

378

2023/2/16

Sawada T, Sato H, Nakasa T.
Migrants' access to COVID-19 vaccination in Japan: Progress and challenges.
J Migr Health. 2023; 7:100169.
Honda A, Tamura T, Baba H, Kodoi H, Noda S. How Hospitals Overcame Disruptions in the Early Stages of the COVID-19

379

2023/2/27

Pandemic: A Case Study from Tokyo, Japan.
Health Syst Reform. 2023; 9(1):2175415.
Vadduri VV, Toyokawa A, Ngoc Hoang Linh N, Nguyen D, Abdul Aziz JM, Ohmagari N, Huy NT.

3802023/2/25

A comprehensive approach to the COVID-19 pandemic in Japan: telemanagement.
Pathog Glob Health. 2023; 117(2):101-103.
Suzuki M, Hayakawa K, Asai Y, Terada M, Kitajima K, Tsuzuki S, Moriya A, Moriya K, Uchiyama-Nakamura F, Ohmagari N.

381

2023/2/20

Characteristics of hospitalized COVID-19 patients with other respiratory pathogens identified by rapid diagnostic test.
J Infect Chemother. 2023:S1341-321X(23)00042-9.

172024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1038/s41467-023-36729-0あり

https://doi.org/10.1016/j.puhe.2023.01.019あり

https://doi.org/10.1038/s41598-023-30305-8なし

https://doi.org/10.3390/ijerph20054546

掲載予定

https://doi.org/10.1017/S0950268823000353

あり

https://doi.org/10.1016/j.jinf.2023.03.006

なし

https://doi.org/10.1016/S1473-3099(23)00132-9

掲載予定

https://doi.org/10.1097/CCE.0000000000000873

あり

Higashi-Kuwata N, Tsuji K, Hayashi H, Bulut H, Kiso M, Imai M, Ogata-Aoki H, Ishii T, Kobayakawa T, Nakano K,
Takamune N, Kishimoto N, Hattori SI, Das D, Uemura Y, Shimizu Y, Aoki M, Hasegawa K, Suzuki S, Nishiyama A,
Saruwatari J, Shimizu Y, Sukenaga Y, Takamatsu Y, Tsuchiya K, Maeda K, Yoshimura K, Iida S, Ozono S, Suzuki T,
382

2023/2/25

Okamura T, Misumi S, Kawaoka Y, Tamamura H, Mitsuya H.
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV2.
Nat Commun. 2023; 14(1):1076.
Shimada Y, Kobayashi Y.

383

2023/2/24

Undocumented immigrants suffering from inequality of vaccination access in Japan: measuring the institutional barriersand exploring the associated factors.
Public Health. 2023; 217:15-21.
Nakayama T, Azegami T, Kiso M, Imai M, Uraki R, Hayashi K, Hishikawa A, Yoshimoto N, Nakamichi R, Sugita-Nishimura E,
Yoshida-Hama E, Kawaoka Y, Itoh H.

384

2023/2/22

Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2
infection.
Sci Rep. 2023 Feb; 13(1):3103.
Uchida M, Okawa S, Hosokawa Y, Tabuchi T.

385

2023/3/3

Decline in Partner-Accompanied Births during the COVID-19 Pandemic in Japan: A Nationwide Cross-Sectional InternetBased Study.
Int. J. Environ. Res. Public Health 2023; 20(5):4546.
Mizoue T, Yamamoto, S Konishi, M Oshiro, Y Inamura, N Nemoto T, Ohmagari N.

386

2023/3/8

Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research center in Tokyo after the
emergence of variants.
Epidemiology & Infection 2023:1-14.
Tamura D, Kawaoka Y.

387

2023/3/6

Omicron proliferation in the nasal cavity may explain its high infectivity.
J Infect. 2023:S0163-4453(23)00135-4.
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Furusawa Y, Imai M, Koga M, Yamamoto S,

388

2023/3/7

Adachi E, Saito M, Tsutsumi T, Otani A, Kashima Y, Kikuchi T, Yotsuyanagi H, Suzuki Y, Kawaoka Y.
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1.
Lancet Infect Dis. 2023:S1473-3099(23)00132-9.
Katagiri D, Asai Y, Ohmagari N, Ishikane M, Hikida S, Iwamoto N, Nagashima M, Suzuki M, Takano H, Takasaki J, Hojo M,3892023/3/9

Sugiyama H, Tokunaga K, Miyashita Y, Omata M, Ohata K, Bliden KP, Tantry US, Dahlen JR, Sugaya T, Gurbel PA, Noiri E.
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases.
Crit Care Explor. 2023; 5(3):e0873.
Yamamoto S, Mizoue T, Ohmagari N.

390

2023/3/16

Analysis of Previous Infection, Vaccinations, and Anti-SARS-CoV-2 Antibody Titers and Protection Against Infection With
the SARS-CoV-2 Omicron BA.5 Variant.

https://doi.org/10.1001/jamanetworkopen.2023.3
370あり

JAMA Netw Open. 2023; 6(3):e233370.
Kamo-Imai A, Togano T, Sato M, Kawakami Y, Inaba K, Shimazu H, Igarashi S, Tanaka K, Terada M, Kinoshita-Iwamoto N,
391

2023/3/18

Saito S, Kutsuna S, Hangaishi A, Morioka S, Takahashi K, Miyata S, Ohmagari N.
The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan.

https://doi.org/10.1016/j.transci.2023.103687

あり

https://doi.org/10.3390/healthcare11060867

あり

https://doi.org/10.35772/ghm.2022.01034

あり

https://doi.org/10.35772/ghm.2022.01046

あり

https://doi.org/10.1111/irv.13109

あり

https://doi.org/10.1007/s00127-023-02460-w

あり

https://doi.org/10.1038/s41598-023-28591-3

あり

https://doi.org/10.1128/jvi.00807-21なし

https://doi.org/10.5582/ddt.2022.01106

あり

https://doi.org/10.1371/journal.pone.0279897

あり

https://doi.org/10.35772/ghm.2022.01070

あり

https://doi.org/10.35772/ghm.2023.01004

あり

Transfus Apher Sci. 2023:103687.
Saeki S, Okada R, Shane PY.
392

2023/3/16

Medical Education during the COVID-19: A Review of Guidelines and Policies Adapted during the 2020 Pandemic.
Healthcare (Basel). 2023; 11(6):867.
Mizumoto Y, Sasaki Y, Sunakawa H, Tanese S, Shinohara R, Kurokouchi T, Sugimoto K, Seto M, Ishida M, Itagaki K,
Yoshida Y, Namekata S, Takahashi M, Harada I, Sasaki S, Saito K, Toguchi Y, Hakosima Y, Inazaki K, Yoshimura Y, Usami

393

2023/3/23

M.
Current situation and clinical burden of pediatricians for children with eating disorders during the COVID-19 pandemic.
Glob Health Med. 2023.
Sugiyama M.

394

2023/3/22

Tools and factors predictive of the severity of COVID-19.
Glob Health Med. 2023.
Furusawa Y, Yamayoshi S, Kawaoka Y.

395

2023/3/17

The accuracy of reverse genetics systems for SARS-CoV-2: Circular polymerase extension reaction versus bacterial
artificial chromosome.
Influenza Other Respir Viruses. 2023; 17(3):e13109.
Shrestha RM, Inoue Y, Yamamoto S, Fukunaga A, Sampei M, Okubo R, Morisaki N, Ohmagari N, Funaki T, Ishizuka K,
Yamaguchi K, Sasaki Y, Takeda K, Miyama T, Kojima M, Nakagawa T, Nishimura K, Ogata S, Umezawa J, Tanaka S, Inoue3962023/3/17

M, Konishi M, Miyo K, Mizoue T.
The association between experience of COVID-19-related discrimination and psychological distress among healthcare
workers for six national medical research centers in Japan.
Soc Psychiatry Psychiatr Epidemiol. 2023:1–9.
Tsuchiya K, Maeda K, Matsuda K, Takamatsu Y, Kinoshita N, Kutsuna S, Hayashida T, Gatanaga H, Ohmagari N, Oka S,

397

2023/1/23

Mitsuya H.
Neutralization activity of IgG antibody in COVID-19-convalescent plasma against SARS-CoV-2 variants.
Sci Rep. 2023; 13(1):1263.
Hayashi Y, Tsuchiya K, Yamamoto M, Nemoto-Sasaki Y, Tanigawa K, Hama K, Ueda Y, Tanikawa T, Gohda J, Maeda K,

398

2021/8/10

Inoue JI, Yamashita A. N-(4-Hydroxyphenyl) Retinamide Suppresses SARS-CoV-2 Spike Protein-Mediated Cell-Cell Fusion
by a Dihydroceramide Δ4-Desaturase 1-Independent Mechanism.
J Virol. 2021; 95(17):e0080721.
Ishii S, Kimura M, Miyoshi-Akiyama T, Moriya A, Kurokawa M, Isaka E, Terada-Hirashima J, Takasaki J, Izumi S, Hojo M,3992023/3/22

Sugiyama H.
Examination of the utility of the COVID-19 detection kit, TRC Ready® SARS-CoV-2 i for nasopharyngeal swabs.
Drug Discov Ther. 2023.
Yamamoto K, Ohsiro Y, Suzuki T, Suzuki M, Miura S, Nagashima M, Iwamoto N, Takeuchi JS, Kimura M, Sugiura W, Nebuya
S, Kurokawa M, Ohmagari N.

400

2023/3/30

Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timingof clinical need for prediction.
PLoS One. 2023; 18(3):e0279897.
Miyazato Y, Tsuzuki S, Matsunaga A, Morioka S, Terada M, Saito S, Iwamoto N, Kutsuna S, Ishizaka Y, Ohmagari N.

401

2023/4/12

Association between SARS-CoV-2 anti-spike antibody titers and the development of post-COVID conditions: A
retrospective observational study.
Glob Health Med. 2023.
Muchanga S M J, Hamana M, Siburian M D, Umano M Ruriko, Kerdsakundee N, Umano M Rejane, Ichikawa M, Iiyama T.

402

2023/4/12

Evolving partnership: A National Center for Global Health and Medicine Resilient Training Model for clinical researchprofessionals during the COVID-19 pandemic.
Glob Health Med. 2023.

18

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.35772/ghm.2023.01024

あり

https://doi.org/10.1371/journal.pone.0283658

なしhttps://doi.org/10.35772/ghm.2023.01018

あり

https://doi.org/10.35772/ghm.2023.01022

掲載予定

https://doi.org/10.3390/ijerph20075408

なし

https://doi.org/10.1080/21645515.2023.2193074

掲載予定

Morishita M, Hojo M.
4032023/4/8

Treatment options for patients with severe COVID-19.
Glob Health Med. 2023.
Li J, Nakagawa T, Kojima M, Nishikimi A, Tokuda H, Nishimura K, Umezawa J, Tanaka S, Inoue M, Ohmagari N, Yamaguchi
K, Takeda K, Yamamoto S, Konishi M, Miyo K, Mizoue T.

4402023/4/6

Underlying medical conditions and anti-SARS-CoV-2 spike IgG antibody titers after two doses of BNT162b2 vaccination: A
cross-sectional study.
PLoS One. 2023; 18(4):e0283658.
Ohmagari N.

405

2023/4/6

Social implications of a change in the legal classification of COVID-19: The need for pandemic prevention, preparedness,and healthcare system strengthening.
Glob Health Med. 2023.
Mikami A, Terada-Hirashima J, Tokita D, Sugiura W.

404

2023/4/8

Clinical trial experience in Japan and future issues in developing drugs to treat COVID-19.
Glob Health Med. 2023.
Morioka N, Kashiwagi M, Machida A, Hanari K, Sugiyama T, Inokuchi R, Tamiya N.

406

2023/4/5

Japanese Local Governments' Dissemination Activities for Advance Care Planning: A Descriptive Analysis of a Nationwide
Survey during the COVID-19 Pandemic.
Int J Environ Res Public Health. 2023; 20(7):5408.
Terada-Hirashima J, Takamatsu Y, Shimizu Y, Uemura Y, Takeuchi JS, Tomita N, Matsuda K, Maeda K, Yamamoto S,
Fukunaga A, Ohmagari N, Mikami A, Sonoda K, Ujiie M, Mitsuya H, Sugiura W.

407

2023/4/13

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label,
single-center, non-randomized, controlled study in Japan.
Hum Vaccin Immunother. 2023;19(1):2193074.
Akiyama Y, Inagaki T, Morioka S, Kusano E, Ohmagari N.

408

2023/4/21

Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (PfizerBioNTech).

https://doi.org/10.2169/internalmedicine.168223

あり

Intern Med. 2023.
加藤 史人, 関原 圭吾, 岡本 竜哉, 井熊 玲央, 小島原 知大, 植村 樹, 木村 昭夫.
409

2022/7/5

重症COVID–19におけるデルタ株流行の影響と予後：単施設後方視研究.

https://doi.org/10.1002/jja2.12728

あり

https://doi.org/10.1007/s13730-023-00792-9あり

https://doi.org/10.1186/s12890-023-02418-3

なし

https://doi.org/10.3892/etm.2023.11984

あり

https://doi.org/10.1186/s12879-023-08272-2あり

https://doi.org/10.1128/spectrum.04311-22なし

https://doi.org/10.1016/j.lanwpc.2023.100777

掲載予定

https://doi.org/10.1016/j.jiac.2023.05.012あり

https://doi.org/10.1002/jmv.28788

掲載予定

https://doi.org/10.1111/jdi.14027

掲載予定

https://doi.org/10.1016/j.cjco.2023.05.006

あり

https://doi.org/10.1093/ofid/ofad274あり

日救急医会誌. 2022; 33(7):291-298.
Terakawa K, Niikura T, Katagiri D, Sugita A, Kikuchi T, Hayashi A, Suzuki M, Takano H.
410

2023/4/27

A case of rapidly progressive glomerulonephritis with double-positive anti-GBM antibody and MPO-ANCA after SARS-CoV2 vaccination and relapse during 1 year follow-up.
CEN Case Rep. 2023.
Nakagawara K, Kamata H, Chubachi S, Namkoong H, Tanaka H, Lee H, Otake S, Fukushima T, Kusumoto T, Morita A,
Azekawa S, Watase M, Asakura T, Masaki K, Ishii M, Endo A, Koike R, Ishikura H, Takata T, Matsushita Y, Harada N,
Kokutou H, Yoshiyama T, Kataoka K, Mutoh Y, Miyawaki M, Ueda S, Ono H, Ono T, Shoko T, Muranaka H, Kawamura K,
Mori N, Mochimaru T, Fukui M, Chihara Y, Nagasaki Y, Okamoto M, Amishima M, Odani T, Tani M, Nishi K, Shirai Y,
Edahiro R, Ando A, Hashimoto N, Ogura S, Kitagawa Y, Kita T, Kagaya T, Kimura Y, Miyazawa N, Tsuchida T, Fujitani S,

411

2023/4/26

Murakami K, Sano H, Sato Y, Tanino Y, Otsuki R, Mashimo S, Kuramochi M, Hosoda Y, Hasegawa Y, Ueda T, Takaku Y,
Ishiguro T, Fujiwara A, Kuwahara N, Kitamura H, Hagiwara E, Nakamori Y, Saito F, Kono Y, Abe S, Ishii T, Ohba T, Kusaka
Y, Watanabe H, Masuda M, Watanabe H, Kimizuka Y, Kawana A, Kasamatsu Y, Hashimoto S, Okada Y, Takano T,
Katayama K, Ai M, Kumanogoh A, Sato T, Tokunaga K, Imoto S, Kitagawa Y, Kimura A, Miyano S, Hasegawa N, Ogawa S,
Kanai T, Fukunaga K; Japan COVID-19 Task Force.
Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
BMC Pulm Med. 2023; 23(1):146.
Hatano H, Sumiya R, Misumi K, Miyazaki H, Ikeda T, Nagasaka S.

412

2023/4/28

Multilocular thymic cyst detected during COVID-19 treatment in an HIV-positive adult man: A case report and literature
review.
Experimental and Therapeutic Medicine. 2023:e04311-22.
Yamamoto S, Matsuda K, Maeda K, Oshiro Y, Inamura N, Mizoue T, Konishi M, Takeuchi JS, Horii K, Ozeki M, Sugiyama H,
Mitsuya H, Sugiura W, Ohmagari N.

413

2023/5/4

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of
BNT162b2.
BMC Infect Dis. 2023; 23(1):282.
Miyazaki T, Hosogaya N, Fukushige Y, Takemori S, Morimoto S, Yamamoto H, Hori M, Ozawa Y, Shiko Y, Inaba Y,
Kurokawa T, Hanaoka H, Iwanami S, Kim K, Iwami S, Watashi K, Miyazawa K, Umeyama T, Yamagoe S, Miyazaki Y, Wakita
T, Sumiyoshi M, Hirayama T, Izumikawa K, Yanagihara K, Mukae H, Kawasuji H, Yamamoto Y, Tarumoto N, Ishii H, Ohno

414

2023/5/4

H, Yatera K, Kakeya H, Kichikawa Y, Kato Y, Matsumoto T, Saito M, Yotsuyanagi H, Kohno S.
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID19.
Microbiol Spectr. 2023:e0431122.
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito

415

2023/5/11

M, Tsutsumi T, Otani A, Kashima Y, Kikuchi T, Theiler J, Yotsuyanagi H, Suzuki Y, Korber B, Kawaoka Y.
Efficacy of antivirals and mRNA vaccination against an XBF clinical isolate.
Lancet Reg Health West Pac. 2023; 34:100777.
Saito S, Kutsuna S, Akifumi I, Hase R, Oda R, Terada J, Shimizu Y, Uemura Y, Takamatsu Y, Yasuhara A, Shiratori K, Satake
M, Sakamoto N, Miyazaki Y, Shimizu H, Togano T, Matsunaga A, Okuma K, Hamaguchi I, Fujisawa K, Nagashima M, Ashida4162023/5/11

S, Terada M, Kimura A, Morioka S, Matsubayashi K, Tsuno NH, Kojima M, Kuramitsu M, Tezuka K, Ikebe E, Ishizaka Y,
Kenji M, Hangaishi A, Mikami A, Sugiura W, Ohmagari N, Mitsuya H.
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial.
J Infect Chemother. 2023:S1341-321X(23)00122-8.
Sakai-Tagawa Y, Yamayoshi S, Halfmann PJ, Wilson N, Bobholz M, Vuyk WC, Wei W, Ries H, O'Connor DH, Friedrich TC,

417

2023/5/13

Sordillo EM, van Bakel H, Simon V, Kawaoka Y.
Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.
J Med Virol. 2023; 95(5):e28788.
Bouchi R, Sugiyama T, Goto A, Ohsugi M, Yoshioka N, Katagiri H, Mita T, Hirota Y, Ikegami H, Matsuhisa M, Araki E,
Yokoyama H, Minami M, Yamazaki K, Jinnouchi H, Ikeda H, Fujii H, Nogawa M, Kaneshige M, Miyo K, Ueki K.

418

2023/5/15

Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients withdiabetes: A multicenter retrospective observational study.
J Diabetes Investig. 2023.
Yamamoto J, Awaya T, Nakagawa T, Tamura A, Hiroi Y.

419

2023/5/18

Myocarditis with ventricular tachycardia following bivalent COVID-19 mRNA vaccination.
CJC Open. 2023.
Ishiguro C, Mimura W, Uemura Y, Maeda M, Murata F, Fukuda H.

420

2023/5/18

Multiregional population-based cohort study for evaluation of the association between herpes zoster and mRNA
vaccinations for SARS-CoV-2: the VENUS Study.
Open Forum Infect Dis. 2023.

19

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/j.cmi.2023.05.020あり

Yamamoto S, Oshiro Y, Inamura N, Nemoto T, Horii K, Okudera K, Konishi M, Ozeki M, Mizoue T, Sugiyama H, Aoyanagi N,
Sugiura W, Ohmagari N.
441

2023/5/24

Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19
vaccine.
Clin Microbiol Infect. 2023; 29(9):1201.e1-1201.e5.
Tanaka K, Meguro S, Itoh A, Kodani N, Itoh H.

421

2023/6/1

Impact of coronavirus disease 2019 in seasonal variation of hemoglobin A1c in adults with type 1 diabetes and the effect ofhttps://doi.org/10.1507/endocrj.EJ23-0085

the mode of treatment: a single-center retrospective study for 2019 and 2021 and analysis by the mode of treatment.

なし

Endocr J. 2023.
Gautier L, Noda S, Chabrol F, David PM, Duhoux A, Hou R, Rosana de Araújo Oliveira S, Traverson L, Zinszer K, Ridde V.
422

2023/5/30

Hospital Governance During the COVID-19 Pandemic: A Multiple-Country Case Study.

https://doi.org/10.1080/23288604.2023.2173551

なし

https://doi.org/10.1016/j.jiac.2023.06.006

なし

https://doi.org/10.35772/ghmo.2023.01000

あり

https://doi.org/10.35772/ghm.2023.01028

あり

https://doi.org/10.35772/ghm.2023.01021

あり

https://doi.org/10.1016/j.ebiom.2023.104677

掲載予定

https://doi.org/10.35772/ghm.2023.01033

あり

https://doi.org/10.35772/ghm.2023.01025

あり

Health Syst Reform. 2023; 9(2):2173551.
Shoji K, Asai Y, Akiyama T, Tsuzuki S, Matsunaga N, Suzuki S, Iwamoto N, Funaki T, Miyairi I, Ohmagari N.
423

2023/6/12

Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis.
J Infect Chemother. 2023:S1341-321X(23)00149-6.
Tomotsugu N, Sakuma N, Dobashi M, Someya M, Imai A, Sakoda J, Fukuda Ｍ, Yoshimoto K, Iiyama T.

424

2023/6/15

Using eConsent to improve patient comprehension and solving issues for introduction, with special attention to the COVID19 pandemic: A questionnaire survey by the Japan Pharmaceutical Manufacturers Association.
GHM Open. 2023.
Kenmotsu Y, Kameoka T.

425

2023/6/20

The COVID-19 pandemic triggered a change in continuing education in nursing: From face-to-face to online education.
Glob Health Med. 2023; 5(3):191-193.
Nozaki I, Tsukada M, Sothy P, Rattana K, Williams K.

426

2023/6/20

Introduction and roll-out of self-learning App for midwifery during the COVID-19 pandemic and its sustainability in
Cambodia.
Glob Health Med. 2023; 5(3):178-183.
Halfmann PJ, Uraki R, Kuroda M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, Kawaoka Y.

427

2023/6/21

Transmission and re-infection of Omicron variant XBB.1.5 in hamsters.
EBioMedicine. 2023; 93:104677.
Nomura S, Kisugi N, Endo K, Omori T.

428

2023/6/25

Parental loneliness, perceptions of parenting, and psychosocial factors among parents having new children during the
COVID-19 pandemic.
Glob Health Med. 2023 ; 5(3):158-168.
Ikemoto M, Matsuo K, Tamura T, Mashino S.

429

2023/6/25

Lessons learned from practices during the initial response to COVID-19 on the cruise ship Diamond Princess.
Glob Health Med. 2023; 5(3):188-190.
Abe K, Kawachi I, Iba A, Miyawaki A.

430

2023/6/22

In-Hospital Deaths From Ambulatory Care-Sensitive Conditions Before and During the COVID-19 Pandemic in Japan.
JAMA Netw Open. 2023; 6(6):e2319583.

https://doi.org/10.1001/jamanetworkopen.2023.1
9583

なし

Umeda A, Baba H, Ishii S, Mizuno S.
431

2023/6/27

Experiences of nurses in charge of COVID-19 critical care patients during the initial stages of the pandemic in Japan.

https://doi.org/10.35772/ghm.2023.01037

あり

https://doi.org/10.1016/j.jiph.2023.05.025あり

Glob Health Med. 2023; 5(3):169-177.
Tsuzuki S, Beutels P.
432

2023/5/25

The estimated disease burden of COVID-19 in Japan from 2020 to 2021.
J Infect Public Health. 2023; 16(8):1236-1243.
茂野 絢子, 大橋 養賢, 増井 良輔, 霧生 彩子, 長島 浩二, 大橋 裕丈, 瀬戸 恵介, 増田 純一, 照屋 勝治, 氏家 無限, 大曲 貴夫, 西村 富

433

2023/6/30

啓.

https://doi.org/10.11150/kansenshogakuzasshi.e

国立国際医療研究センター病院におけるニルマトレルビル/リトナビル導入に向けた取り組みと導入後の実態調査.

22043

あり

感染症学雑誌. 2023; 97(4):125-135.
Omata K, Shimazaki A.
434

2023/7/5

Wavelet analysis of COVID-19 pandemic.

https://doi.org/10.15748/jasse.10.214あり

https://doi.org/10.1038/s41467-023-39704-x

掲載予定

https://doi.org/10.1186/s12985-023-02113-z

なし

https://doi.org/10.31662/jmaj.2023-0034

あり

https://doi.org/10.1186/s13030-023-00285-2あり

https://doi.org/10.1038/s41598-023-40225-2なし

https://doi.org/10.1016/j.lanwpc.2023.100885

あり

https://doi.org/10.1016/j.jinf.2023.08.012

なし

https://doi.org/10.1016/j.jiac.2023.09.005

あり

https://doi.org/10.1080/23744235.2023.2254380

なし

https://doi.org/10.1080/16549716.2023.2258707

なし

Journal of Advanced Simulation in Science and Engineering. 2023; 10 (2):214-220.
Kiso M, Furusawa Y, Uraki R, Imai M, Yamayoshi S, Kawaoka Y.
435

2023/7/4

In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir.
Nat Commun. 2023; 14(1):3952.
Ishizaka A, Koga M, Mizutani T, Uraki R, Yamayoshi S, Iwatsuki-Horimoto K, Yamamoto S, Imai M, Tsutsumi T, Suzuki Y,

436

2023/7/13

Kawaoka Y, Yotsuyanagi H.
Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
Virol J. 2023; 20(1):146.
Kaneko T, Saeki S.

437

2023/7/14

Research Collaborations in the Post-COVID Era.
JMA J. 2023; 6(3):358-359.
Kawai K, Tachimori H, Yamamoto Y, Nakatani Y, Iwasaki S, Sekiguchi A, Kim Y, Tamura N.

438

2023/8/9

Trends in the effect of COVID-19 on consultations for persons with clinical and subclinical eating disorders.
Biopsychosoc Med. 2023; 17(1):29.
Nishimura E, Shoki R, Kato M, Yoneoka D, Okawa S, Tabuchi T, Ota E.

439

2023/8/22

Factors associated with father-infant bonding during the COVID-19 pandemic: an internet-based cross-sectional study inJapan.
Sci Rep. 2023; 13(1):13653.
Yamaguchi T, Iwagami M, Ishiguro C, Kitao S, Tetsuhashi M, Izumi M, Yoshihara S, Kobatake H, Banzai Y, Kinoshita N,
Iguchi T, Oka A, Morio T, Nakai K, Hayashi S, Takagi R.

442

2023/8/25

Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for Omicron variants and vaccinations for
infants and young children.
Lancet Reg Health West Pac. 2023; 38:100885.
Amano M, Ichikawa Y, Matsumoto S, Matsushita S, Shimada S, Mitsuya H.

443

2023/9/1

Longitudinal analysis of neutralization in sera from HCWs receiving 2 doses of Omicron BA.4/5-adapted bivalent vaccine.
J Infect. 2023:S0163-4453(23)00464-4.
Asai Y, Ohashi T, Imai K, Murata K, Tsuzuki S, Matsunaga N, Ohmagari N.

444

2023/9/9

Differences in COVID-19 treatment across Japan: Analysis of the COVID-19 Registry Japan (COVIREGI-JP).
J Infect Chemother. 2023:S1341-321X(23)00210-6.
Shimasaki S, Baba T, Ogura T, Akasaka K, Matsushima H, Izumi S, Takasaki J, Tsushima K, Kinouchi T, Kichikawa Y,
Awashima M, Izumo T, Awano N, Nishimura N, Tazawa R, Mikami A, Kitamura N, Ishii H, Kurihara Y, Taniguchi M, Aikawa

445

2023/9/20

S, Okada M, Morita Y, Ishikawa Y, Ohinata A, Nakata K.
Short-term inhalation of sargramostim with concomitant high-dose steroids does not hasten recovery in moderate COVID19 pneumonia: a double-blind, randomised, placebo-controlled trial.
Infect Dis (Lond). 2023 :1-17.
Nomura S, Ghaznavi C, Shimizu K, Cao A, Sassa M, Uchibori M, Santosh Kumar R, Yamasaki L, Tomoi H, Sakamoto H.

446

2023/9/21

Insights from the COVID-19 pandemic: trends in development assistance committee countries' aid allocation, 2011-2021.
Glob Health Action. 2023; 16(1):2258707.

202024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.2188/jea.JE20230106

あり

https://doi.org/10.1093/infdis/jiad317あり

https://doi.org/10.1016/j.jinf.2023.09.009

掲載予定

https://doi.org/10.1016/j.bmcl.2023.129489

なしhttps://doi.org/10.1021/acs.jmedchem.3c00777

なし

https://doi.org/10.1016/j.heliyon.2023.e20568

あり

https://doi.org/10.1016/j.isci.2023.108147

掲載予定

https://doi.org/10.1172/jci.insight.172510

なし

https://doi.org/10.7133/jca.23-00018

あり

https://doi.org/10.7889/tct-23-016

なし

https://doi.org/10.1093/ofid/ofad475あり

https://doi.org/10.5582/ddt.2023.01078

あり

https://doi.org/10.35772/ghm.2023.01049

あり

https://doi.org/10.1016/j.vaccine.2023.10.037

あり

https://doi.org/10.3390/life13112184あり

https://doi.org/10.1111/jcpp.13907

なし

https://doi.org/10.35772/ghm.2023.01053

あり

https://doi.org/10.1177/03946320231216314

なし

https://doi.org/10.1038/s41598-023-47577-9あり

https://doi.org/10.3390/v15122280

掲載予定

https://doi.org/10.1016/j.jmii.2023.12.002あり

https://doi.org/10.1016/j.celrep.2023.113580

あり

Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Sato S, Kawazoe Y, Maeda M, Murata F, Fukuda H.
447

2023/9/23

Effectiveness of BNT162b2 against infection, symptomatic infection, and hospitalization among older adults aged ≥65
years during the Delta variant predominance in Japan: The VENUS Study.
J Epidemiol. 2023.
Yamamoto S, Matsuda K, Maeda K, Horii K, Okudera K, Oshiro Y, Inamura N, Nemoto T, Takeuchi JS, Li Y, Konishi M,
Tsuchiya K, Gatanaga H, Oka S, Mizoue T, Sugiyama H, Aoyanagi N, Mitsuya H, Sugiura W, Ohmagari N.

449

2023/9/26

Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched
Analysis.
J Infect Dis. 2023:jiad317.
Yamamoto S, Mizoue T, Konishi M, Oshiro Y, Inamura N, Nemoto T, Tan T, Sugiura W, Ohmagari N.

4502023/9/26

Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2 reinfection.
J Infect. 2023:S0163-4453(23)00511-X.
Ghosh AK, Shahabi D, Imhoff MEC, Kovela S, Sharma A, Hattori SI, Higashi-Kuwata N, Mitsuya H, Mesecar AD.

451

2023/9/27

SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads.
Bioorg Med Chem Lett. 2023:129489.
Tsuji K, Ishii T, Kobayakawa T, Higashi-Kuwata N, Shinohara K, Azuma C, Miura Y, Nakano H, Wada N, Hattori SI, Bulut H,
Mitsuya H, Tamamura H.

452

2023/9/27

Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2carbonyl Moieties.
J Med Chem. 2023.
Suzuki T, Asai Y, Takahashi K, Sanada M, Shimanishi Y, Terada M, Sato L, Inada M, Yamada G, Akiyama Y, Oshiro Y,
Shiratori K, Togano T, Takamatsu Y, Maeda K, Matsunaga A, Ishizaka Y, Nomoto H, Iwamoto N, Saito S, Kutsuna S,

448

2023/9/29

Morioka S, Ohmagari N.
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.
Heliyon. 2023; 9(10):e20568.
Uraki R, Ito M, Kiso M, Yamayoshi S, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Imai M, Koga M, Yamamoto S, Adachi E, Saito

453

2023/10/4

M, Tsutsumi T, Otani A, Fukushi S, Watanabe S, Suzuki T, Kikuchi T, Yotsuyanagi H, Maeda K, Kawaoka Y.
Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate,iScience. 2023:108147.
Kingstad-Bakke B, Cleven T, Bussan H, Yount BL Jr, Uraki R, Iwatsuki-Horimoto K, Koga M, Yamamoto S, Yotsuyanagi H,

454

2023/10/5

Park H, Mishra JS, Kumar S, Baric R, Halfmann PJ, Kawaoka Y, Suresh M.
Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine.
JCI Insight. 2023:e172510.
廣井 透雄.

455

2023/10/10

COVID-19の心血管疾患への影響
脈管学. 2023; 63 (7):109-113.
服部 浩一, 島津 浩, 長田 太郎, 高橋 聡, ハイジッヒ ベアテ.

456

2023/10/16

サイトカインストーム症候群における細胞外プロテアーゼの機能解明と新規治療戦略.
日本造血・免疫細胞療法学会雑誌. 2023:12(4).
Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Maeda M, Murata F, Fukuda H.

457

2023/10/17

Bivalent Vaccine Effectiveness Among Adults Aged ≥65 Years During the BA.5-Predominant Period in Japan: The VENUS
Study.
Open Forum Infect Dis. 2023; 10(10):ofad475.
Suzuki M, Matsunaga A, Miyoshi-Akiyama T, Terada-Hirashima J, Sadamasu K, Nagashima M, Takasaki J, Izumi S, Hojo M,
Ishizaka Y, Sugiyama H.

458

2023/10/30

Inhaled ciclesonide does not affect production of antibodies or elimination of virus in patients with COVID-19: Subanalysis
of a multicenter, open-label randomized trial.
Drug Discov Ther. 2023.
Wakabayashi M, Hachiya M, Fujita N, Komada K, Obara H, Nozaki I, Okawa S, Saito E, Katsuma Y, Iso H.

459

2023/11/5

How did COVID-19 impact development assistance for health? – The trend for country-specific disbursement between
2015 and 2020.
Glob Health Med. 2023:5(6); 328-385.
Inoue Y, Li Y, Yamamoto S, Fukunaga A, Ishiwari H, Ishii M, Miyo K, Ujiie M, Sugiura W, Ohmagari N, Mizoue T.

462

2023/11/7

The association between antipyretic analgesics use and SARS-CoV-2 antibody titers following the second dose of the
BNT162b2 mRNA vaccine: An observational study.
Vaccine. 2023:S0264-410X(23)01220-3.
Terada M, Saito S, Kutsuna S, Kinoshita-Iwamoto N, Togano T, Hangaishi A, Shiratori K, Takamatsu Y, Maeda K, Ishizaka

461

2023/11/9

Y, Ohtsu H, Satake M, Mitsuya H, Ohmagari N.
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals.
Life 2023; 13(11):2184.
DeVylder J, Yamaguchi S, Hosozawa M, Yamasaki S, Ando S, Miyashita M, Endo K, Stanyon D, Usami S, Kanata S, Tanaka

463

2023/11/13

R, Minami R, Hiraiwa-Hasegawa M, Kasai K, Nishida A.
Adolescent psychotic experiences before and during the COVID-19 pandemic: a prospective cohort study.
J Child Psychol Psychiatry. 2023.
Kamegai K, Iwamoto N, Ishikane M, Yamamoto K, Horii K, Kubota S, Hangaishi A, Shimazu H, Togano T, Yamashita H,

460

2023/11/15

Yamada Y, Ohmagari N.
A novel protocol for de-isolating moderately and severely immunocompromised COVID-19 patients.
Glob Health Med. 2023:5(6); 366-371.
Sugimoto R, Kenzaka T, Mikami A, Matsunaga N, Akiyama T, Ohmagari N, Nishisaki H.

464

2023/11/17

Steroid initiation timing and outcome of coronavirus disease 2019 patients: A multicenter, retrospective, observational
study.
Int J Immunopathol Pharmacol. 2023; 37:3946320231216314.
Matsumoto S, Nagai M, Tran LK, Yamaoka K, Nguyen HDT, Dinh Van T, Tanuma J, Pham TN, Oka S, Van Tran G.

465

2023/11/21

Multicenter observational survey on psychosocial and behavioral impacts of COVID-19 in people living with HIV in Northern
Vietnam.
Sci Rep. 2023; 13(1):20321.
Iwatsuki-Horimoto K, Ito M, Okuda-Hamabata M, Takagi H, Imai M, Kawaoka Y.

466

2023/11/21

Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k
Hamster Model.
Viruses. 2023; 15(12):2280.
Suzuki T, Asai Y, Tsuzuki S, Nomoto H, Matsunaga N, Kodama EN, Hayakawa K, Ohmagari N.
Real-world effectiveness of full and booster mRNA vaccination for coronavirus disease 2019 against disease severity

467

2023/12/10

during the delta- and omicron-dominant phases: A propensity score-matched cohort study using the nationwide registrydata in Japan.
J Microbiol Immunol Infect. 2023:S1684-1182(23)00216-5.
Uraki R, Kiso M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, Chiba S, Sakai-Tagawa Y, Imai M, Kashima Y, Koga M, Fuwa N,

468

2023/12/15

Okumura N, Hojo M, Iwamoto N, Kato H, Nakajima H, Ohmagari N, Yotsuyanagi H, Suzuki Y, Kawaoka Y.
Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo.
Cell Rep. 2023; 42(12):113580.

21

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1073/pnas.2314808120

なし

Miyamoto S, Nishiyama T, Ueno A, Park H, Kanno T, Nakamura N, Ozono S, Aihara K, Takahashi K, Tsuchihashi Y, Ishikane
M, Arashiro T, Saito S, Ainai A, Hirata Y, Iida S, Katano H, Tobiume M, Tokunaga K, Fujimoto T, Suzuki M, Nagashima M,
469

2023/12/22

Nakagawa H, Narita M, Kato Y, Igari H, Fujita K, Kato T, Hiyama K, Shindou K, Adachi T, Fukushima K, NakamuraUchiyama F, Hase R, Yoshimura Y, Yamato M, Nozaki Y, Ohmagari N, Suzuki M, Saito T, Iwami S, Suzuki T.
Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infection.
Proc Natl Acad Sci U S A. 2023:S1684-1182(23)00216-5.
Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T, Inoue M, Sakai-Tagawa Y, Ito M, Yamayoshi S,
Iwatsuki-Horimoto K, Suzuki Y, Kawaoka Y.

470

2024/1/2

Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological
Malignancies.

https://doi.org/10.2169/internalmedicine.290023

なしInternal Medicine. 2024.
Uraki R, Imai M, Ito M, Yamayoshi S, Kiso M, Jounai N, Miyaji K, Iwatsuki-Horimoto K, Takeshita F, Kawaoka Y.
471

2024/1/3

An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants.

https://doi.org/10.1038/s41541-023-00800-0あり

https://doi.org/10.1186/s12866-023-03157-5なし

https://doi.org/10.1016/j.heliyon.2024.e24513

あり

https://doi.org/10.7759/cureus.52592

あり

https://doi.org/10.1007/s00535-023-02071-x

なし

https://doi.org/10.56741/jphs.v3i01.466

なし

https://doi.org/10.1007/s00737-024-01424-6

なし

https://doi.org/10.1038/s41598-024-53199-6なし

https://doi.org/10.1016/j.ejmech.2024.116132

なし

https://doi.org/10.1016/j.clnesp.2024.02.005

あり

https://doi.org/10.5365/wpsar.2023.14.5.1048

あり

NPJ Vaccines. 2024; 9(1):4.
Ishizaka A, Koga M, Mizutani T, Yamayoshi S, Iwatsuki-Horimoto K, Adachi E, Suzuki Y, Kawaoka Y, Yotsuyanagi H.
472

2024/1/3

Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV. BMC Microbiol.
2024; 24(1):6.
Iwamoto N, Takamatsu Y, Asai Y, Tsuchiya K, Matsuda K, Oshiro Y, Inamura N, Terada M, Nemoto T, Kimura M, Saito S,
Morioka S, Maeda K, Mitsuya H, Ohmagari N.

473

2024/1/13

High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral
neutralizing activity.
Heliyon. 2024; e24513.
Iwasaki M, Hashimoto M, S.Takeuchi J, Kusaba Y, Kimura M, Terada-Hirashima J, Sugiura W, Hojo M.

4742024/1/19

Relapse of COVID-19 and Viral Evolution in a Patient With Good Syndrome: A Case Report.
Cureus. 2024; 16(1): e52592.
Matsubara Y, Kiyohara H, Mikami Y, Nanki K, Namkoong H, Chubachi S, Tanaka H, Azekawa S, Sugimoto S, Yoshimatsu Y,
Sujino T, Takabayashi K, Hosoe N, Sato T, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano

475

2024/1/25

S, Ogawa S, Fukunaga K, Kanai T; The Japan COVID-19 Task Force.
Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study.
J Gastroenterol. 2024.
Tomono M, Ando S, Kamau-Mitchell C, Ihara S, Isobe A, Kido H, Sanji S, Watanabe T, Tokuda H, Itokazu D, Tokuda Y.

476

2024/1/26

Burnout and Fear of COVID-19 among Medical Students in Japan.
Journal of Public Health Sciences. 2024.
Chen C, Mochizuki Y, Okawa S, Okubo R,Nakagawa S, Tabuchi T.

477

2024/1/26

Postpartum loneliness predicts future depressive symptoms: a nationwide Japanese longitudinal study.
Arch Womens Ment Health. 2024.
Okushin K, Tateishi R, Hirakawa S, Tachimori H, Uchino K, Nakagomi R, Yamada T, Nakatsuka T, Minami T, Sato M,
Fujishiro M, Kiyoshi Hasegawa K, Eguchi Y, Kanto T, Yoshiji H, Izumi N, Kudo M, Koike K.

478

2024/2/3

The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liverdiseases (REAL).
Sci Rep. 2024.
Ghosh AK, Yadav M, Iddum S, Ghaz S, Lendy EK, Jayashankar U, Beechboard SN, Takamatsu Y, Hattori S, Aamano M,
Higashi-Kuwata N, Mitsuya H, Mesecar AD.

479

2024/2/1

Exploration of P1 and P4 modifications of nirmatrelvir: Design, synthesis, biological evaluation, and X-ray structural studies
of SARS-CoV-2 Mpro inhibitors☆
Eur J Med Chem. 2024.
Ito A, Yamamoto S, Oshiro Y, Inamura N, Nemoto T, Tan T, Konishi M, Mizoue T, Aoyanagi N, Sugiyama H, Sugiura W,

480

2024/2/7

Ohmagari N.
Vitamin D deficiency during the coronavirus disease 2019 (COVID-19) pandemic among healthcare workers.
Clin Nutr ESPEN. 2024; 60:210-216.
Moriyama Y, Takaya S, Nishijima T, Sobel H L, Ohmagari N.

481

2024/2/6

Maintaining health-system functionality in response to the surge of COVID-19 cases due to the Omicron variant, Japan.
Western Pac Surveill Response J. 2024; 14(5):1-6.
Islam Z, Yamamoto S, Mizouea T, Konishi M, Ohmagari N.

482

2024/2/10

483

2024/2/14

Coffee and green tea consumption with the risk of COVID-19 among the vaccine recipients in Japan.

https://doi.org/10.2188/jea.JE20230231

J Epidemiol. 2024.

掲載予定

Sato L, Iwamoto N, Kakumoto Y, Tsuzuki S, Togano T, Ishikane M, Okumura N, Yamada G, Inada M, Suzuki T, Hojo M,
Takasaki J, Sasaki R, Kimura A, Teruya K, Okamoto T, Hayakawa K, Hara H, Iseki K, Ohmagari N.
Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan.

https://doi.org/10.5551/jat.64448

あり

https://doi.org/10.1002/pcn5.175あり

https://doi.org/10.1007/s10157-023-02456-5あり

https://doi.org/10.1186/s12890-024-02917-x

あり

https://doi.org/10.1002/cpt.3224

なし

https://doi.org/10.2188/jea.JE20230285

あり

https://doi.org/10.1016/j.jviromet.2024.114909

あり

J Atheroscler Thromb. 2024.
Usami M, Satake N, Katsuyama H, Okudera K, Uchiyama Y, Imamura M, Hayakawa T, Yanai H, Aoyanagi N.
484

2024/2/13

Is children's mental health an important function of newly
Psychiatry Clin. Neurosci. Rep. 2024;3:e175.
Noiri E, Katagiri D, Asai Y, Sugaya T, Tokunaga K.

485

2024/2/24

Urine oxygenation predicts COVID-19 risk.
Clin Exp Nephrol. 2024.
Tsukada A, Terada-Hirashima J, Takasaki J, Nokihara H, Izumi S, Hojo M. Sugiyama H.

486

2024/3/2

Clinical trends among patients with asthma hospitalized for COVID-19 based on data from a nationwide database: anobservational study.
BMC Pulm Med. 2024; 24(1):105.
Sasaki M, Sato H, Uemura Y, Mikami A, Ichihara N, Fujitani S, Kondo M, Doi Y, Morino E, Tokita D, Ohmagari N, Sugiura W,
Hirakawa A.

487

2024/3/5

How Much More Efficient Are Adaptive Platform Trials Than Multiple Stand-Alone Trials? A Comprehensive Simulation
Study for Streamlining Drug Development During a Pandemic.
Clin Pharmacol Ther. 2024.
Ishiguro C, Mimura W, Terada J, Matsunaga N, Ishiwari H, Hoshimoto H, Miyo K, Ohmagari N.

488

2024/3/9

Development and validation of claims-based algorithms for identifying hospitalized patients with COVID-19 and theirseverity in 2020 and 2021.
J Epidemiol. 2024.
Katsuno T, Kimura M, Terada-Hirashima J, Kazuyama Y, Ikeda M, Moriya A, Kurokawa M, Motohashi A, Isaka E, Morishita
M, Kawajiri K, Hakkaku K, Saito S, Terayama Y, Sugiura Y, Yamaguchi Y, Takumida H, Watanabe H, Morita C, Tsukada A,
Kusaba Y, Tsujimoto Y, Ishida A, Sakamoto K, Hashimoto M, Suzuki M, Takasaki J, Izumi S, Hojo M, Sugiyama H, Sugiura489

2024/3/5

W.
Diagnostic accuracy of direct reverse transcription-polymerase chain reaction using guanidine-based and guanidine-free
inactivators for SARS-CoV-2 detection in saliva samples.
J Virol Methods. 2024; 326:114909.

222024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1016/j.ijid.2024.107008

あり

https://doi.org/10.1038/s42003-024-06015-w

掲載予定

https://doi.org/10.23736/S2724-6612.22.02373-9あり

https://doi.org/10.35772/ghmo.2023.01025

あり

https://doi.org/10.35772/ghmo.2023.01014

あり

https://doi.org/10.1007/s00737-024-01467-9なし

https://doi.org/10.1038/s41440-024-01682-y

なし

https://doi.org/10.2188/jea.JE20230360

なし

https://doi.org/10.1016/j.jinf.2024.106179

なし

https://doi.org/10.7759/cureus.60202

なし

https://doi.org/10.1126/scitranslmed.adl1722

なし

https://doi.org/10.1080/21645515.2024.2350091

あり

https://doi.org/10.35772/ghmo.2024.01003

あり

https://doi.org/10.1038/s41598-024-63330-2あり

https://doi.org/10.1186/s12879-024-09427-5

なし

https://doi.org/10.1038/s41598-024-63078-9

なし

https://doi.org/10.35772/ghm.2024.01035

あり

https://doi.org/10.1111/irv.13338

あり

https://doi.org/10.1186/s12939-024-02234-z

あり

https://doi.org/10.35772/ghm.2023.01134

あり

Hosozawa M, Hori M, Hayama-Terada M, Arisa I, Mph YM, Kitamura A, Takayama Y, Iso H.
490

2024/3/8

Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan:
A matched case-control study in the general population.
Int J Infect Dis. 2024;143:107008.
Halfmann PJ, Iwatsuki-Horimoto K, Kuroda M, Hirata Y, Yamayoshi S, Iida S, Uraki R, Ito M, Ueki H, Furusawa Y, Sakai-

491

2024/3/15

Tagawa Y, Kiso M, Armbrust T, Spyra S, Maeda K, Wang Z, Imai M, Suzuki T, Kawaoka Y.
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters.
Commun Biol. 2024; 7(1):331.

Murakami H, Kanda M, Sawayanagi T.
492

2024/3/22

Serious psychological distress and Coronavirus disease 2019 impact among population affected by relative poverty inJapan: an online cross-sectional study.
Minerva Psychiatry 2024;65(1):28-36.
Sakurai A, Morioka S, Tsuzuki S, Matsunaga N, Saito S, Arai N, Yamamoto N, Hara T, Hojo M, Hiroi Y, Yamada K,
Ohmagari N.

493

2024/3/30

Difference in clinical courses and causes of COVID-19-related deaths in hospitalized patients infected with omicron anddelta variants: A retrospective study in Japan.
GHM Open. 2024.
Susumu Yagome, Mitsuru Ohsugi, Takehiro Sugiyama, Ryotaro Bouchi, Atsushi Goto, Kohjiro Ueki.

494

2024/3/29

Trends in prescription days and intervals between physician visits and their impact on glycemic control before and during
the COVID-19 pandemic in Japan.
GHM Open. 2024.
Hagiwara K, Chen C, Okubo R, Okawa S, Nakagawa S, Tabuchi T.

495

2024/4/11

Identifying distinct subtypes of mother-to-infant bonding using latent profile analysis in a nationwide Japanese study.
Arch Womens Ment Health. 2024.
Yoshihara F, Matsuzawa Y, Nakatsuka K, Kirigaya J, Takeuchi I, Kimura K, Konishi M, Tamura K, Fukui K, Tsukahara K,
Shimizu H, Iwabuchi K, Yamada Y, Saka K, Sato Y, Ogawa M, Hayakawa K, Ohmagari N, Ikeda S, Akao M, Shimomura H,

496

2024/4/26

Kihara Y, Yoshimoto A, Morita M, Kumada N, Ogata S, Nishimura K, Arisato T, Matsuo M, Kishida M, Yasuda S, Ogawa H.
Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients
admitted to hospital.
Kurotori I, R. Asakura T, Kimura T, Hori M, Hosozawa M, Saijo M, Iso H, Tamakoshi A.

497

2024/5/11

The Association between COVID-19-Related Discrimination and Probable Post Traumatic Stress Disorder among Patientswith COVID-19 in Sap.
Journal of Epidemiology. 2024.
Amano M, Ichikawa Y, Matsumoto S, Higashi-Kuwata N, Takamatsu Y, Matsushita S, Shimada S, Mitsuya H.

498

2024/5/11

Neutralization activity of HCWs’ sera after Omicron XBB.1.5-adapted monovalent COVID-19 mRNA vaccination.
Journal of Infection. 2024.
Kuribara T, Asai Y, Ohmagari N, Yokota I.

499

2024/5/13

Status of COVID-19 Patients Treated With Extracorporeal Membrane Oxygenation in Japan: Nationwide Database Analysis.
Cureus. 2024; 16(5): e60202.
Mühlemann B, Wilks SH, Baracco L, Bekliz M, Carreño JM, Corman VM, Davis-Gardner ME, Dejnirattisai W, Diamond MS,
Douek DC, Drosten C, Eckerle I, Edara VV, Ellis M, Fouchier RAM, Frieman M, Godbole S, Haagmans B, Halfmann PJ,

500

2024/5/15

Henry AR, Jones TC, Katzelnick LC, Kawaoka Y, Kimpel J, Krammer F, Lai L, Liu C, Lusvarghi S, Meyer B, Mongkolsapaya J,
Montefiori DC, Mykytyn A, Netzl A, Pollett S, Rössler A, Screaton GR, Shen X, Sigal A, Simon V, Subramanian R, Supasa P,
Suthar MS, Türeli S, Wang W, Weiss CD, Smith DJ.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.

501

2024/5/17

Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS study.
Hum Vaccin Immunother. 2024;20(1):2350091.
Maruki T, Morioka S, Kutsuna S, Kimura Y, Mochizuki H, Ohmagari N.

502

2024/5/23

The potential association between COVID-19 and Parkinson's diseaselike symptoms.
GHM Open. 2024.
Katagiri D, Tsukada A, Izumi S, Shimizu Y, Terada-Hirashima J, Uemura Y, Kusaba Y, Takasaki J, Takoi H, Tamura-Nakano

503

2024/5/31

M, Hojo M, Takano H, Noiri E, Abe S, Azuma A, Sugiyama H.
Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapy.
Sci Rep. 2024; 14(1):12550.
Takayama Y, Xu YS, Shimakawa Y, Chowell G, Kozuka M, Omori R, Matsuyama R, Yamamoto T, Mizumoto K.

504

2024/5/30

Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020-2022,
Okinawa prefecture, Japan.
BMC Infect Dis. 2024; 24(1):542.
Gando S, Akiyama T.

505

2024/5/30

Disseminated intravascular coagulation is associated with poor prognosis in patients with COVID-19.
Sci Rep. 2024;14(1):12443.
Yokobori Y, Nozaki I, Hachiya M, Fujita M, Egami Y, Miyano S, Nagai M, Komada K, Norizuki M, Ichimura Y, Tsuboi M,

506

2024/6/16

Kawachi N, Takakura S.
Strengthening health systems during non-pandemic period: Toward universal health coverage in the pandemic agreement.
Glob Health Med. 2024.
Ohmagari N, Yotsuyanagi H, Doi Y, Yamato M, Imamura T, Sakaguchi H, Yamanaka H, Imaoka R, Fukushi A, Ichihashi G,
Sanaki T, Tsuge Y, Uehara T, Mukae H.

507

2024/6/18

Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter,
Randomized, Phase 2b/3 Clinical Trial.
Influenza Other Respir Viruses. 2024; 18(6):e13338.
Taniguchi Y, Tamiya N, Iwagami M, Yamagishi K, Miyawaki A, Masuda R, Kihara T, Komiyama J, Tachikawa H, Takahashi

508

2024/7/31

H, Iso H.
Different trends in suicide rates among foreign residents in Japan and Japanese citizens during the COVID-19 pandemic.
Int J Equity Health. 2024; 23(1):150.
Shimanuki Y, Shimomura A, Ogawa C, Komuro M, Terakado H, Nishimura T, Shimizu C.
A retrospec tive single institutional analysis of outpatient chemotherapy in patients with cancer during the COVID-19

509

2024/8/3

pandemic.
Glob Health Med. 2024.

23

2024/08/19 更新
通し番号オンラインリリース日

論文Citation

DOI情報

邦文要旨掲載有無

https://doi.org/10.1186/s41182-024-00621-4あり

https://doi.org/10.35772/ghmo.2024.01007

掲載予定

https://doi.org/10.35772/ghmo.2024.01008

掲載予定

Thandar MM, Iwamoto A, Hoshino HA, Sudo K, Fujii M, Kanda M, Ikeda S, Fujita M.
510

2024/8/6

Factors associated with the uptake of COVID-19 vaccination, testing and medical care among Myanmar migrants in Japan:
a cross-sectional study.
Trop Med Health. 2024; 52(1):53.
Horie Y, Ishiguro C, Mimura W, Maeda M, Murata F, Fukuda H.

511

2024/8/19

Validity of vaccination information in the COVID-19 surveillance system in Japan: Implications for developing efficient andhighly valid data collection systems in future pandemics
GHM Open. 2024.
Estrada CA, Usami M, Satake N, Gregorio E Jr, Leynes C, Balderrama N, Fernandez de Leon J, Concepcion RA, Timbalopez
C, Cainghug VK, Tsujii N, Harada I, Masuya J, Kihara H, Kawahara K, Yoshimura Y, Hakoshima Y, Kobayashi J.

512

2024/8/19

2020 and 2021 web-based training program on children's mental health during the COVID-19 pandemic.
GHM Open. 2024.

24